Our unaudited condensed financial statements for the six months
period ended February 28, 2017 form part of this quarterly report. They are
stated in United States Dollars (US$) and are prepared in accordance with United
States generally accepted accounting principles.
ENERTOPIA CORP.
(A Development Stage
Company)
CONDENSED BALANCE SHEETS (unaudited)
(Expressed in U.S. Dollars)
|
|
February 28
|
|
|
August 31
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
Cash and cash equivalents
|
$
|
93,155
|
|
$
|
31,034
|
|
Marketable
securities (Note 4)
|
|
-
|
|
|
18,780
|
|
Accounts receivable
|
|
18,466
|
|
|
11,012
|
|
Prepaid expenses
and deposit
|
|
77,437
|
|
|
83,286
|
|
Total current assets
|
|
189,058
|
|
|
144,112
|
|
|
|
|
|
|
|
|
Non-Current
|
|
|
|
|
|
|
Long term
investments in affiliated company (Note 5)
|
|
-
|
|
|
1
|
|
Mineral Property (Note 6)
|
|
95,750
|
|
|
83,750
|
|
Long term
investments (Note 5)
|
|
1
|
|
|
1
|
|
Lithium Technology (Note 7)
|
|
22,500
|
|
|
12,500
|
|
Total Assets
|
$
|
307,309
|
|
$
|
240,364
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
Accounts payable
|
$
|
233,675
|
|
$
|
236,242
|
|
Shares Subscription Received
|
|
-
|
|
|
1,334
|
|
Due to related
parties (Note 8)
|
|
183,001
|
|
|
138,923
|
|
Total Current
Liabilities
|
|
416,676
|
|
|
376,499
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Share capital
|
|
|
|
|
|
|
Authorized:
200,000,000
common shares with a par value of $0.001 per
share
Issued and
outstanding:
98,812,031
common shares at February 28, 2017 and August 31,2016: 89,528,460
|
|
98,812
|
|
|
89,528
|
|
Additional paid-in capital
|
|
12,623,660
|
|
|
12,214,934
|
|
Deficit accumulated during
the exploration stage
|
|
(12,831,839
|
)
|
|
(12,440,597
|
)
|
Total Stockholders' Equity
|
|
(109,367
|
)
|
|
(136,135
|
)
|
Total Liabilities and
Stockholders' Equity
|
$
|
307,309
|
|
$
|
240,364
|
|
The accompanying notes are an integral part of these condensed
financial statements
F-1
ENERTOPIA
CORP.
(A
Development
Stage
Company)
CONDENSED
STATEMENTS
OF
STOCKHOLDERS'
EQUITY
(unaudited)
(Expressed
in U.S.
Dollars)
|
|
COMMON STOCK
|
|
|
ADDITIONAL
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
|
|
|
|
PAID-IN
|
|
|
DEFICIT
|
|
|
STOCKHOLDERS'
|
|
|
|
SHARES
|
|
|
AMOUNT
|
|
|
CAPITAL
|
|
|
ACCUMULATED
|
|
|
EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, August 31,
2015
|
|
71,508,460
|
|
|
71,508
|
|
|
11,884,661
|
|
|
(11,915,096
|
)
|
|
41,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based Compensation
|
|
|
|
|
|
|
|
37,107
|
|
|
|
|
|
37,107
|
|
Stock issued for Consulting Agreement
|
|
100,000
|
|
|
100
|
|
|
900
|
|
|
|
|
|
1,000
|
|
Shares issued for Definitive
Agreement May 12
|
|
3,500,000
|
|
|
3,500
|
|
|
61,250
|
|
|
|
|
|
64,750
|
|
Shares issued for Stock Option exercise May
12
|
|
240,000
|
|
|
240
|
|
|
11,760
|
|
|
|
|
|
12,000
|
|
Shares issued for PP on May
20
|
|
6,413,333
|
|
|
6,413
|
|
|
61,464
|
|
|
|
|
|
67,877
|
|
Shares issued for PP on June 8
|
|
3,016,667
|
|
|
3,017
|
|
|
30,027
|
|
|
|
|
|
33,044
|
|
Shares issued for PP on
August 9
|
|
4,500,000
|
|
|
4,500
|
|
|
115,515
|
|
|
|
|
|
120,015
|
|
Shares issued per LOI dated August 16
|
|
250,000
|
|
|
250
|
|
|
12,250
|
|
|
|
|
|
12,500
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) for the year
|
|
|
|
|
|
|
|
|
|
|
(525,501
|
)
|
|
(525,501
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, August 31, 2016
|
|
89,528,460
|
|
|
89,528
|
|
|
12,214,934
|
|
|
(12,440,597
|
)
|
|
(136,135
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based Compensation
|
|
|
|
|
|
|
|
138,774
|
|
|
|
|
|
138,774
|
|
Shares issued for PP on
September 23
|
|
3,858,571
|
|
|
3,859
|
|
|
93,792
|
|
|
|
|
|
97,651
|
|
Shares issued for Definitive Agreement May
12, Oct 7
|
|
175,000
|
|
|
175
|
|
|
6,825
|
|
|
|
|
|
7,000
|
|
Shares issued for PP on
January 20
|
|
1,000,000
|
|
|
1,000
|
|
|
28,792
|
|
|
|
|
|
29,792
|
|
Shares issued for PP on February 28
|
|
4,250,000
|
|
|
4,250
|
|
|
114,925
|
|
|
|
|
|
119,175
|
|
Warrant options issued on
February 28
|
|
|
|
|
|
|
|
25,618
|
|
|
|
|
|
25,618
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)
for the year
|
|
|
|
|
|
|
|
|
|
|
(391,242
|
)
|
|
(391,242
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, February 28,
2017
|
|
98,812,031
|
|
|
98,812
|
|
|
12,623,660
|
|
|
(12,831,839
|
)
|
|
(109,367
|
)
|
The accompanying notes are an integral part of these condensed
financial statements
F-2
Enertopia Corp.
(A Development Stage
Company)
CONDENSED STATEMENTS OF OPERATIONS (unaudited)
(Expressed in U.S. Dollars)
|
|
THREE
MONTHS ENDED
|
|
|
SIX MONTHS
ENDED
|
|
|
|
February 28
|
|
|
February 29
|
|
|
February 28
|
|
|
February 29
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
-
|
|
|
2,204
|
|
|
-
|
|
|
14,014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Product Sales
|
|
-
|
|
|
(1,499
|
)
|
|
-
|
|
|
(7,515
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
-
|
|
|
705
|
|
|
-
|
|
|
6,499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounting and audit
|
|
6,563
|
|
|
(12,039
|
)
|
|
21,363
|
|
|
27,961
|
|
Sales
& Marketing
|
|
-
|
|
|
21
|
|
|
-
|
|
|
1,801
|
|
Advertising &
Promotions
|
|
55,935
|
|
|
10,002
|
|
|
79,079
|
|
|
20,563
|
|
Bank
charges and interest expense
|
|
561
|
|
|
2,629
|
|
|
1,813
|
|
|
4,616
|
|
Consulting/Stock Based
Compensation
|
|
135,704
|
|
|
50,605
|
|
|
214,478
|
|
|
141,486
|
|
Mineral
exploration costs
|
|
1,160
|
|
|
-
|
|
|
32,669
|
|
|
-
|
|
Fees and dues
|
|
7,157
|
|
|
12,952
|
|
|
18,425
|
|
|
22,250
|
|
Insurance
|
|
3,219
|
|
|
4,428
|
|
|
6,767
|
|
|
8,861
|
|
Investor relations
|
|
-
|
|
|
1,363
|
|
|
4,111
|
|
|
6,368
|
|
Legal and
professional
|
|
1,758
|
|
|
4,083
|
|
|
8,094
|
|
|
25,781
|
|
Office and miscellaneous
|
|
2,983
|
|
|
7,746
|
|
|
604
|
|
|
5,942
|
|
Research
and Development
|
|
-
|
|
|
1,460
|
|
|
-
|
|
|
4,608
|
|
Rent
|
|
4,114
|
|
|
5,324
|
|
|
8,838
|
|
|
11,472
|
|
Telephone
|
|
886
|
|
|
815
|
|
|
1,583
|
|
|
1,345
|
|
Training &
Conferences
|
|
-
|
|
|
-
|
|
|
-
|
|
|
666
|
|
Travel
|
|
5,206
|
|
|
959
|
|
|
5,733
|
|
|
1,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
225,246
|
|
|
90,348
|
|
|
403,557
|
|
|
285,416
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) for the period
before other items
|
|
(225,246
|
)
|
|
(89,643
|
)
|
|
(403,557
|
)
|
|
(278,917
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense
|
|
-
|
|
|
10,000
|
|
|
-
|
|
|
20,000
|
|
Gain (loss) on marketable securities
|
|
(282
|
)
|
|
(74,435
|
)
|
|
12,316
|
|
|
(45,049
|
)
|
Impairment of long term
investments
|
|
(1
|
)
|
|
-
|
|
|
(1
|
)
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
and comprehensive loss for the period
|
$
|
(225,529
|
)
|
$
|
(154,078
|
)
|
$
|
(391,242
|
)
|
$
|
(303,966
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted income (loss) per
share
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common
shares
outstanding - basic and diluted
|
|
93,670,835
|
|
|
71,536,238
|
|
|
91,811,606
|
|
|
71,522,272
|
|
The accompanying notes are an integral part of these condensed
financial statements
F-3
ENERTOPIA CORP.
(A Development Stage
Company)
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(Expressed in U.S. Dollars)
|
|
SIX MONTHS
ENDED
|
|
|
|
February 28
|
|
|
February 29
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Cash flows used in
operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (loss)
|
$
|
(391,242
|
)
|
$
|
(303,966
|
)
|
Changes to
reconcile net loss to net cash used in operating activities
|
|
|
|
|
|
|
Consulting - Stock based compensation
|
|
138,774
|
|
|
37,107
|
|
Stock issued for services
|
|
25,618
|
|
|
1,000
|
|
Gain on owned securities
|
|
(12,317
|
)
|
|
45,049
|
|
Impairment of long term investments
|
|
1
|
|
|
-
|
|
Change in non-cash working capital items:
|
|
|
|
|
|
|
Accounts receivable
|
|
(7,454
|
)
|
|
18,898
|
|
Prepaid expenses and deposit
|
|
5,849
|
|
|
2,544
|
|
Inventory
|
|
-
|
|
|
6,796
|
|
Deferred charges
|
|
-
|
|
|
(20,000
|
)
|
Accounts payable and accrued liabilities
|
|
(3,901
|
)
|
|
41,039
|
|
Due to related parties
|
|
44,078
|
|
|
31,810
|
|
Net cash (used in) operating
activities
|
|
(200,594
|
)
|
|
(139,723
|
)
|
|
|
|
|
|
|
|
Cash flows from (used in) investing
activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale
of marketable securities
|
|
31,097
|
|
|
93,911
|
|
Mineral resource properties acquisition
|
|
(5,000
|
)
|
|
-
|
|
Acquisition of
Lithium technologies
|
|
(10,000
|
)
|
|
-
|
|
|
|
|
|
|
|
|
Net cash from (used in) investing
activities
|
|
16,097
|
|
|
93,911
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
Net proceeds from subscriptions received
|
|
246,618
|
|
|
-
|
|
|
|
|
|
|
|
|
Net cash from financing
activities
|
|
246,618
|
|
|
-
|
|
|
|
|
|
|
|
|
Increase (Decrease) in
cash and cash equivalents
|
|
62,121
|
|
|
(45,812
|
)
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
31,034
|
|
|
84,157
|
|
|
|
|
|
|
|
|
Cash and cash equivalents,
end of period
|
$
|
93,155
|
|
$
|
38,345
|
|
The accompanying notes are an integral part of these condensed
financial statements
F-4
ENRTOPIA CORP.
|
NOTES TO CONDENSED FINANCIAL STATEMENTS
(unaudited)
|
February 28, 2017
|
(Expressed in U.S. Dollars)
|
|
The unaudited condensed financial
statements for the period ended February 28, 2017 included herein have been
prepared pursuant to the rules and regulations of the Securities and Exchange
Commission. Certain information and footnote disclosures normally included in
annual financial statements prepared in accordance with United States generally
accepted accounting principles have been condensed or omitted pursuant to such
rules and regulations. In the opinion of management, all adjustments (consisting
of normal recurring accruals) considered necessary for a fair presentation have
been included. These unaudited condensed financial statements should be read in
conjunction with the August 31, 2016 audited annual financial statements and
notes thereto.
The Company was formed on November 24,
2004 under the laws of the State of Nevada and commenced operations on November
24, 2004. The Company was an independent natural resource company engaged in the
exploration, development and acquisition of natural resources in the United
States and Canada. In the fiscal year 2010, the Company shifted its strategic
plan from its non-renewal energy operations to its planned renewal energy
operations and natural resource acquisition and development. In late summer of
2013, the Company had another business sector in alternative health and
wellness. During spring of 2016, the Company shifted its strategic plan to
natural resource acquisitions and Lithium brine extraction technology. The
Company has offices in Vancouver and Kelowna, B.C., Canada.
2.
|
GOING CONCERN UNCERTAINTY
|
The accompanying unaudited condensed
financial statements have been prepared on a going concern basis which
contemplates the realization of assets and the satisfaction of liabilities and
commitments in the normal course of business for the foreseeable future. The
Company had a working capital deficit of $227,618 for the quarter ended February
28, 2017 [deficit of $232,387 for the year ended August 31, 2016]. The Company
incurred a net loss of $391,242 for the six months ended February 28, 2017 [net
loss of $303,967 for the six months ended February 29, 2016] and as at February
28, 2017 has incurred cumulative losses of $12,831,839 that raises substantial
doubt about its ability to continue as a going concern. Management has been
able, thus far, to finance the operations through equity financing and cash on
hand. There is no assurance that the Company will be able to continue to finance
the Company on this basis.
In view of these conditions, the
ability of the Company to continue as a going concern is in substantial doubt
and dependent upon its ability to generate sufficient cash flow to meet its
obligations on a timely basis, to obtain additional financing as may be
required, to receive the continued support of the Companys shareholders, and
ultimately to obtain successful operations. There are no assurances that we will
be able to obtain further funds required for our continued operations. As noted
herein, we are pursuing various financing alternatives to meet our immediate and
long-term financial requirements. There can be no assurance that additional
financing will be available to us when needed or, if available, that it can be
obtained on commercially reasonable terms. If we are not able to obtain the
additional financing on a timely basis, we will be unable to conduct our
operations as planned, and we will not be able to meet our other obligations as
they become due. In such event, we will be forced to scale down or perhaps even
cease our operations. There is significant uncertainty as to whether we can
obtain additional financing. These unaudited condensed financial statements do
not give effect to any adjustments which would be necessary should the Company
be unable to continue as a going concern and therefore be required to realize
its assets and discharge its liabilities in other than the normal course of
business and at amounts different from those reflected in the accompanying
unaudited condensed financial statements.
3.
|
SIGNIFICANT ACCOUNTING
POLICIES
|
The accompanying unaudited condensed
financial statements have been prepared in accordance with accounting principles
generally accepted in the United States (U.S. GAAP) for interim financial
information and the instructions to Securities and Exchange Commission (SEC)
Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the
information and footnotes required by U.S. GAAP for complete financial
statements. Therefore, these financial statements should be read in conjunction
with our audited financial statements and notes thereto for the year ended
August 31, 2016.
The preparation of financial statements
in conformity with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of expenses during the
reporting period. On an ongoing basis, we evaluate our estimates, judgments, and
assumptions, including those related to revenue recognition, inventory
valuation, and stock based compensation (expense and liability). Our estimates,
judgments, and assumptions are based on historical experience, future
expectations, and other factors which we believe to be reasonable. Actual
results could differ from those estimates and assumptions.
c)
|
Recently Adopted Accounting
Pronouncements
|
In May 2015, the FASB issued guidance
to remove the requirement to categorize within the fair value hierarchy all
investments for which fair value is measured using net asset value per share
practical expedient. The guidance is effective for the Company in the first
quarter of fiscal 2017 and early adoption is permitted. Adoption of the new
guidance, effective for the quarter beginning September 1, 2017, had no impact
on the Companys balance sheets or statements of operations or cash flows.
d)
|
New Accounting
Pronouncements
|
In March 2016, the FASB issued guidance
which simplifies several aspects of accounting for share-based payment award
transactions including income tax consequences, classification of awards as
either equity or liabilities and classification on the statement of cash flows.
The guidance is effective for the Company in the first quarter of fiscal 2018
and earlier adoption is permitted. The Company is evaluating the impact of
adopting this new accounting guidance on its financial statements.
In June 2016, the FASB issued guidance
that changes the accounting for recognizing impairments of financial assets.
Under the new guidance, credit losses for certain types of financial instruments
will be estimated based on expected losses. The new guidance also modifies the
impairment models for available for-sale debt securities and for purchased
financial assets with credit deterioration since their origination. The guidance
is effective for the Company in the first quarter of fiscal 2021 and earlier
adoption is permitted. The Company is evaluating the impact of adopting this new
accounting guidance on its financial statements.
In August 2014, the FASB issued
guidance on how to account for and disclose going concern risk. The new standard
requires management to perform interim and annual assessments of an entity's
ability to continue as a going concern within one year of the date of issuance
of the entity's financial statements (or within one year after the date on which
the financial statements are available to be issued, when applicable). Further,
an entity must provide certain disclosures if there is "substantial doubt about
the entity's ability to continue as a going concern." The ASU is effective for
annual periods ending after December 15, 2016, and interim periods thereafter
and early adoption is permitted. The Company has adopted the methodologies
prescribed by this ASU by the date required and there is no material impact on
the Companys financial statements.
As at February 28, 2017 all marketable
securities of the common shares of Lexaria Corp. obtained through Definitive
Agreements that was signed on March 5, 2014 has been liquidated.
During the quarter end February 28,
2017, the Company disposed of 22,500 (February 29, 2016: 279,000) common shares
of Lexaria Corp. with a cost basis of $7,313 (February 29, 2016: $25,110). The
proceeds from the sales of sales were $5,118 (February 29, 2016: $59,100).
Accordingly, a loss of $282 (February 29, 2016: $33,990) was recognized in
profit and loss.
Global Solar Water Power Systems
Inc. (GSWPS)
On February 28, 2010, the Company
entered into an Asset and Share Purchase Agreement with the Companys former
chief technical officer - Mr. Mark Snyder to acquire up to 20% ownership
interest of GSWPS.
During the year ended August 31, 2013,
based on the managements assessment of GSWPSs current operations, the Company
decided to write down long-term investment in GSWPS to $1.
Pro Eco Energy USA Ltd.
During the year ended August 31, 2008,
the Company purchased 900,000 shares in Pro Eco Energy USA Ltd. (Pro Eco
Energy) for $45,000. During the year ended August 31, 2014, the Company sold
its investment in Pro Eco Energy to Western Standard Energy Corp. for $40,000.
During the year ended August 31, 2015, 600,000 shares of Pro Eco Energy were
returned to the Company and the receivable from Western Standard Energy Corp.
was settled. The Company has no significant influence in Pro Eco Energy.
The value of Pro Eco Energys shares
have been written down to $1 by management during the year ended August 31, 2016
based on the managements assessment of Pro Eco Energys current operations.
As at February 28, 2017, Pro Eco Energy
announced it will be closing out the company and the asset was written down to
nil.
Enertopia has signed the Definitive
Agreement (the Agreement) on May 12,
2016 with Brandon Wilson
Association respecting the option to purchase a 100% interest in approximately
2,560 acres of placer mining claims in Churchill, Lander and Nye Counties
Nevada, USA. These placer mining claims are subject to a 1.5% NSR from
commercial production with the Company able to buy back the NSR at the rate of
$500,000 per 0.5% NSR.
The consideration payable by Enertopia
to Brandon Wilson Association consist of:
|
(a)
|
paying $7,000 on signing the Offer; (paid)
|
|
(b)
|
paying $12,000 on signing of the Agreement and issuing
3,500,000 common shares in the capital stock of Enertopia as soon as
practicable following the execution of the Agreement, (paid and
issued)
|
|
(c)
|
paying an optional $12,000 on or before the six month
anniversary of the Agreement; (paid and issued 175,000 common shares of
the company. Refer to Note 9)
|
|
(a)
|
paying an optional $22,500 on or before the one year
anniversary of the Agreement.
|
The Company is also required to issue
additional common shares upon the discovery of a Lithium enriched brine with an
average 300ppm Li over 100 foot vertical interval in the enriched lithium brine
in the Central Nevada Brine Project. Further, 1,000,000 Bonus Shares will be
issued per each successful property discovery meeting the foregoing criteria up
to a maximum 3,000,000 Bonus Shares.
7.
|
PREPAID FOR LITHIUM
TECHNOLOGY
|
On August 15, 2016 a binding Letter of
Intent (LOI) was signed by Enertopia and Genesis Water Technologies, Inc.
("GWT") with regard to the acquisition by Enertopia of the exclusive worldwide
licensing rights (the "Licensing Rights") by Enertopia of all of the technology
used in the process of recovering and extraction of battery grade lithium
carbonate powder Li2CO3 grading 99.5% or higher purity from brine solutions.
Upon the execution of this LOI,
Enertopia issued 250,000 common shares valued at $12,500 to GWT.
On December 6, 2016, Enertopia and GWT
signed a Definitive Commercial Agreement with regard to the acquisition by
Enertopia of the exclusive licensing rights of all of the technology used in the
process of recovering and extraction of battery grade lithium carbonate powder
Li2CO3 grading 99.5% or higher purity from brine solutions.
The following are key points of the
terms of the formal Definitive Commercial Agreement:
|
a)
|
Enertopia to pay within 30 days to GWT $10,000 for the
bench testing of four lithium brine samples to confirm the June 2016
feasibility report. Upon successful independent 3
rd
party lab
testing of the bench test results, final location will be confirmed for
permitting and construction of 50 gpm test pilot facility which will take
approximately three months to build. (paid)
|
|
b)
|
Upon successful test pilot facility results, start the
construction of commercial Lithium recovery production facility.
|
|
c)
|
GWT has granted Enertopia exclusive rights and
relicensing rights to the usage of GWTs patent pending technology
covering United States of America, Argentina, Bolivia and Chile as per the
Commercialization Agreement in return for 10 per cent of net sales royalty
payments for battery grade Lithium Carbonate Li2CO3 produced.
|
|
d)
|
In order to maintain its exclusive rights, Enertopia will
need to make the following minimal payments to GWT on the anniversary of
signing the definitive agreement:
|
|
a.
|
On or before December 6, 2017, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$50,000;
|
|
b.
|
On or before December 6, 2018, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$150,000;
|
|
c.
|
On or before December 6, 2019, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$200,000;
|
|
d.
|
For 2019 to 2023, the greater of 10 per cent of Enertopia
net Lithium Carbonate Li2CO3 sales from brine sources or $200,000 per
annum.
|
|
e.
|
Right of first refusal to renew exclusive rights and
relicensing rights for another 10 years after the first seven year
licensing period on the same net sales terms as those of 2023 or $250,000
per annum.
|
8.
|
RELATED PARTIES
TRANSACTION
|
For the six months ended February 28,
2017, the Company was party to the following related party transactions:
|
|
Incurred $39,000 (February 28, 2016: $39,000) to the
President of the Company in consulting fees.
|
|
|
Incurred CAD$45,000 (February 28, 2016: CAD$45,000) in
consulting fees to a company controlled by the CFO of the Company.
|
|
|
$183,001 (August 31, 2016: $138,923) was payable to the
President and a company controlled by the CFO of the Company.
|
|
|
Incurred share based compensation expenses of
$51,070 in relation to stock options issued to officers and directors of
the Company (February 28, 2016: $24,404).
|
The related party transactions are
recorded at the exchange amount established and agreed to between the related
parties.
On September 23, 2016, the Company
closed the final tranche of a private placement of 3,858,571 units at a price of
CAD$0.035 per unit for gross proceeds of CAD$135,050. Each unit consists of one
common share of the Company and one non-transferable share purchase warrant,
each full warrant entitling the holder to purchase one additional common share
of the Company for a period of 24 months from the date of issuance, at a
purchase price $0.07. A cash finders fee of CAD$4,830 and 138,000 full broker
warrants that expire September 23, 2018 was paid to Canacorrd Genuity and Leede
Jones Gable Inc.
On October 7, 2016, the Company issued
175,000 shares per the definitive agreement signed on May 12, 2016 to purchase a
100% interest in approximately 2,560 acres of placer mining claims in Churchill,
Lander and Nye Counties Nevada, USA. Also see Note 6.
On January 20, 2017, the Company closed
the first tranche of a private placement of 1,000,000 units at a price of
CAD$0.04 per unit for gross proceeds of CAD $40,000. Each unit consists of one
common share of the Company and one-nontransferable share purchase warrant, each
full warrant entitling the holder to purchase one additional common share of the
Company for a period of 24 months from the date of issuance, at a purchase price
of $0.06. A cash finders fee of CAD$800 and 20,000 full broker warrants that
expire January 20, 2019 was paid to Leede Jones Gable Inc.
On February 28, 2017, the Company
closed the first tranche of a private placement of 4,250,000 units at a price of
CAD$0.04 per unit for gross proceeds of CAD $170,000. Each unit consists of one
common share of the Company and one-nontransferable share purchase warrant, each
full warrant entitling the holder to purchase one additional common share of the
Company for a period of 24 months from the date of issuance, at a purchase price
of $0.06. A cash finders fee of CAD$11,100 and 227,500 full broker warrants
that expire February 28, 2019 was paid to Leede Jones Gable Inc., Canaccord
Genuity and Duncan McKay.
As at February 28, 2017 the Company had
98,812,031 shares issued and outstanding and August 31, 2016, the Company had
89,528,460 shares issued and outstanding.
10.
|
STOCK OPTIONS AND WARRANTS
|
Stock Options
On July 15, 2014, the shareholders
approved and adopted at the Annual General Meeting the Companys 2014 Stock
Option Plan. On April 14, 2011, the shareholders approved and adopted at the
Annual General Meeting to consolidate the Companys 2007 Equity compensation
plan and the Companys 2010 Equity Compensation Plan into a new Company 2011
Stock Option Plan. The purpose of these Plans is to advance the interests of the
Corporation, through the grant of Options, by providing an incentive mechanism
to foster the interest of eligible persons in the success of the Corporation and
its affiliates; encouraging eligible persons to remain with the Corporation or
its affiliates; and attracting new Directors, Officers, Employees and
Consultants.
On November 3, 2014 the Company granted
2,100,000 stock options to directors, officers, and consultant of the Company
with an exercise price of $0.10 vested immediately, expiring November 3, 2019.
On November 18, 2014, the Company
granted 100,000 stock options to consultant of the Company with an exercise
price of $0.10 vested immediately, expiring November 13, 2019.
On October 23, 2015, the Company
granted 1,850,000 stock options to directors, officers and consultant of the
Company with an exercise price of $0.05 vested immediately, expiring October 23,
2020.
On September 19, 2016, the Company
granted 800,000 stock options to consultant of the Company with an exercise
price of $0.07 vested immediately, expiring September 19, 2021.
On January 20, 2017, the Company
granted 1,535,000 stock options to directors, officers and consultant of the
Company with an exercise price of $0.07 vested immediately, expiring January 20,
2022.
On January 31, 2017, the Company
granted 1,500,000 stock options to consultant of the Company with an exercise
price of $0.07 vested immediately, expiring January 31, 2022.
For the six months ended February 28,
2017, the Company recorded $138,774 (February 29, 2016 $37,107) stock based
compensation expenses which has been included in consulting fees.
A summary of the changes in stock
options for the six months ended February 28, 2017 is presented below:
|
|
|
Options Outstanding
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
Number of Shares
|
|
|
Exercise Price
|
|
|
Balance, August 31, 2016
|
|
3,210,000
|
|
$
|
0.07
|
|
|
Cancelled
|
|
(250,000
|
)
|
|
0.06
|
|
|
Granted
|
|
3,835,000
|
|
|
0.07
|
|
|
Balance, February 28, 2017
|
|
6,795,000
|
|
$
|
0.07
|
|
The fair value of options granted has
been estimated as of the date of the grant by using the Black-Scholes option
pricing model with the following assumptions:
|
|
|
February 28, 2017
|
|
|
August 31, 2016
|
|
|
Expected volatility
|
|
139%-147%
|
|
|
220%-217%
|
|
|
Risk-free interest rate
|
|
1.22%-1.95%
|
|
|
1.25%-1.43%
|
|
|
Expected life
|
|
5.00 years
|
|
|
5.00 years
|
|
|
Dividend yield
|
|
0.00%
|
|
|
0.00%
|
|
|
Estimated fair value per option
|
|
$0.03-$0.04
|
|
|
$0.01-$0.05
|
|
The Company has the following options
outstanding and exercisable.
|
February 28, 2017
|
|
Options
outstanding
|
|
|
Options
exercisable
|
|
|
|
|
Number
|
|
|
Remaining
|
|
|
Exercise
|
|
|
Number
|
|
|
Exercise
|
|
|
Exercise prices
|
|
of shares
|
|
|
contractual
|
|
|
Price
|
|
|
of shares
|
|
|
Price
|
|
|
|
|
|
|
|
life
|
|
|
|
|
|
exercisable
|
|
|
|
|
|
$0.07
|
|
1,500,000
|
|
|
4.92 years
|
|
$
|
0.07
|
|
|
1,500,000
|
|
$
|
0.07
|
|
|
$0.07
|
|
1,535,000
|
|
|
4.89 years
|
|
$
|
0.07
|
|
|
1,535,000
|
|
$
|
0.07
|
|
|
$0.07
|
|
800,000
|
|
|
4.56 years
|
|
$
|
0.07
|
|
|
800,000
|
|
$
|
0.07
|
|
|
$0.05
|
|
1,460,000
|
|
|
3.65 years
|
|
$
|
0.05
|
|
|
1,560,000
|
|
$
|
0.05
|
|
|
$0.10
|
|
1,000,000
|
|
|
2.68 years
|
|
$
|
0.10
|
|
|
1,050,000
|
|
$
|
0.10
|
|
|
$0.06
|
|
500,000
|
|
|
1.68 years
|
|
$
|
0.06
|
|
|
500,000
|
|
$
|
0.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,795,000
|
|
|
3.73 years
|
|
$
|
0.07
|
|
|
6,795,000
|
|
$
|
0.07
|
|
|
August 31, 2016
|
|
Options
outstanding
|
|
|
Options
exercisable
|
|
|
|
|
Number
|
|
|
Remaining
|
|
|
Exercise
|
|
|
Number
|
|
|
Exercise
|
|
|
Exercise prices
|
|
of shares
|
|
|
contractual
|
|
|
Price
|
|
|
of shares
|
|
|
Price
|
|
|
|
|
|
|
|
life
|
|
|
|
|
|
exercisable
|
|
|
|
|
|
$0.05
|
|
100,000
|
|
|
4.43 years
|
|
$
|
0.05
|
|
|
100,000
|
|
$
|
0.05
|
|
|
$0.05
|
|
1,560,000
|
|
|
4.14 years
|
|
$
|
0.05
|
|
|
1,560,000
|
|
$
|
0.05
|
|
|
$0.10
|
|
1,050,000
|
|
|
3.17 years
|
|
$
|
0.10
|
|
|
1,050,000
|
|
$
|
0.10
|
|
|
$0.06
|
|
500,000
|
|
|
2.18 years
|
|
$
|
0.06
|
|
|
500,000
|
|
$
|
0.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,210,000
|
|
|
3.53 years
|
|
$
|
0.07
|
|
|
3,210,000
|
|
$
|
0.07
|
|
Warrants
On December 16, 2015, the Company
submitted to the CSE the Form 13 for extending two classes of warrants by two
years with all other terms and conditions remaining the same. The Company
approved the expiry extension from January 31, 2016 till January 31, 2018 on
2,167,160 warrants that remain outstanding as of November 30, 2016 from the
non-brokered private placement that closed on January 31, 2014. The Company
approved the expiry extension from February 13, 2016 till February 13, 2018 on
7,227,340 warrants that remain outstanding as of November 30, 2016 from the
non-brokered private placement that closed on February 13, 2014. The warrants
were evaluated against ASC 815 Derivatives and Hedging, and determined to be
equity instrument at initial recognition.
On September 23, 2016, the Company
closed the final tranche of a private placement of 3,858,571 units at a price of
CAD$0.035 per unit for gross proceeds of CAD$135,050. Each unit consists of one
common share of the Company and one non-transferable share purchase warrant,
each full warrant entitling the holder to purchase one additional common share
of the Company for a period of 24 months from the date of issuance, at a
purchase price $0.07. A cash finders fee of CAD$4,830 and 138,000 full broker
warrants that expire September 23, 2018 was paid to Canacorrd Genuity and Leede
Financial.
On January 20, 2017, the Company closed
the first tranche of a private placement of 1,000,000 units at a price of
CAD$0.04 per unit for gross proceeds of CAD $40,000. Each unit consists of one
common share of the Company and one-nontransferable share purchase warrant, each
full warrant entitling the holder to purchase one additional common share of the
Company for a period of 24 months from the date of issuance, at a purchase price
of $0.06. A cash finders fee of CAD$800 and 20,000 full broker warrants that
expire January 20, 2019 was paid to Leede Jones Gable Inc.
On February 28, 2017, the Company
closed the first tranche of a private placement of 4,250,000 units at a price of
CAD$0.04 per unit for gross proceeds of CAD $170,000. Each unit consists of one
common share of the Company and one-nontransferable share purchase warrant, each
full warrant entitling the holder to purchase one additional common share of the
Company for a period of 24 months from the date of issuance, at a purchase price
of $0.06. A cash finders fee of CAD$11,100 and 227,500 full broker warrants that expire February 28, 2019 was paid to Leede Jones
Gable Inc., Canaccord Genuity and Duncan McKay.
On February 28, 2017, the Company
signed a Letter of Engagement with Adam Mogil and issued 1,000,000 warrant
options to convert to 1,000,000 common shares to Adam Mogil to provide corporate
services. The warrants have an exercise price of $0.09 and expire August 28,
2017.
A summary of warrants as at February
28, 2017 and August 31, 2016 is as follows:
|
|
|
Warrant Outstanding
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
Number of warrant
|
|
|
Exercise Price
|
|
|
Balance, August 31, 2016
|
|
29,412,139
|
|
$
|
0.09
|
|
|
Expired
|
|
(2,906,800
|
)
|
|
0.10
|
|
|
Issued
|
|
10,494,071
|
|
|
0.07
|
|
|
Balance, February 28, 2017
|
|
36,999,410
|
|
$
|
0.09
|
|
|
Number
|
Exercise
|
Expiry
|
|
Outstanding
1
|
Price
|
Date
|
|
4,477,500
|
$0.06
|
February 28, 2019
|
|
1,000,000
|
$0.09
|
August 28, 2017
|
|
1,020,000
|
$0.06
|
January 20,2019
|
|
2,167,160
|
$0.15
|
January 31, 2018
|
|
7,227,340
|
$0.15
|
February 13, 2018
|
|
1,787,640
|
$0.10 and $0.15 after 24 months
|
January 30, 2018
|
|
637,200
|
$0.10 and $0.15 after 24 months
|
March 12, 2018
|
|
6,882,666
|
$0.05 and $0.10 after 18 months
|
May 20, 2019
|
|
3,303,333
|
$0.05 and $0.10 after 18 months
|
June 8, 2019
|
|
4,500,000
|
$0.07
|
August 9, 2018
|
|
3,996,571
|
$0.07
|
September 23, 2018
|
|
36,999,410
|
|
|
|
1.
|
Each warrant entitles a holder to purchase one common
share.
|
|
(a)
|
The Company has a consulting agreement with the President
of the Company for corporate administration and consulting services for
$5,000 per month plus HST/GST on a continuing basis. Effective March 1,
2014, the Company entered into a new consulting contract with the
consulting services at $6,500 per month plus GST.
|
|
|
|
|
(b)
|
On October 9, 2009, the Company entered into consulting
agreement with BKB Management Ltd., a corporation organized under the laws
of the Province of British Columbia. BKB Management Ltd. is a consulting
company controlled by the chief financial officer of the Company. BKB
Management provides management consulting services for CAD$4,500 per month
plus HST/GST. Effective April 1, 2011, the consulting services are
CAD$5,500 per month plus HST/GST. Effective March 1, 2014, the Company
entered into a new consulting agreement with the consulting services at
CAD$7,500 per month plus GST.
|
|
|
|
|
(c)
|
On September 19, 2016, the Company entered into a one
year Investor Relations Consulting agreement with Duncan McKay. Based on
the terms of the agreement, Mr. McKay can earn up to a maximum of 10%
commissions on capital raised.
|
(a)
Item 2. Managements Discussion and
Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This quarterly report contains forward-looking statements as
that term is defined in the Private Securities Litigation Reform Act of 1995.
These statements relate to future events or our future financial performance. In
some cases, you can identify forward-looking statements by terminology such as
"may", "should", "expects", "plans", "anticipates", "believes", "estimates",
"predicts", "potential" or "continue" or the negative of these terms or other
comparable terminology. These statements are only predictions and involve known
and unknown risks, uncertainties and other factors, including the risks in the
section entitled "Risk Factors", that may cause our or our industry's actual
results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking statements. Although
we believe that the expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity, performance
or achievements. Except as required by applicable law, including the securities
laws of the United States, we do not intend to update any of the forward-looking
statements to conform these statements to actual results.
Our unaudited condensed financial statements are stated in
United States Dollars (US$) and are prepared in accordance with United States
Generally Accepted Accounting Principles. The following discussion should be
read in conjunction with our unaudited condensed financial statements and the
related notes that appear elsewhere in this quarterly report. The following
discussion contains forward-looking statements that reflect our plans, estimates
and beliefs. Our actual results could differ materially from those discussed in
the forward looking statements. Factors that could cause or contribute to such
differences include, but are not limited to, those discussed below and elsewhere
in this quarterly report, particularly in the section entitled "Risk Factors" of
this quarterly report.
In this quarterly report, unless otherwise specified, all
dollar amounts are expressed in United States dollars. All references to "CDN$"
refer to Canadian dollars and all references to "common shares" refer to the
common shares in our capital stock.
As used in this quarterly report, the terms "we", "us", "our"
and "Company" mean Company and/or our subsidiaries, unless otherwise indicated.
Overview
Enertopia Corp. was formed on November 24, 2004 under the laws
of the State of Nevada and commenced operations on November 24, 2004.
From inception until April 2010, we were primarily engaged in
the acquisition and exploration of natural resource properties. Beginning in
April 2010, we began our entry into the renewable energy sector by purchasing an
interest in a solar thermal design and installation company. In late summer
2013, we began our entry into medicinal marijuana business. During our 2014
fiscal year end our activities in the clean energy sector were discontinued.
During fiscal 2015 our activities in the Medicinal Marijuana sector were also
discontinued.
The Company is actively pursuing business opportunities in the
resource sector, whereby we signed a definitive agreement for a Lithium Brine in
May 2016. The Company continued in the health and wellness sector throughout
2015 and 2016, where the Company had launched a womens health product. For
strategic reasons the Company had discontinued the manufacturing and retail
distribution of the womens health product at the end of fiscal 2016. The
Companys main focus is in natural resource sector and patent pending technology
used for Lithium extraction through brines.
The address of our principal executive office is Suite 950,
1130 West Pender Street, Vancouver, British Columbia V6E 4A4. Our telephone
number is (604) 602-1675. In addition, we have a second office located in
Kelowna, British Columbia. Our current locations provide adequate office space
for our purposes at this stage of our development.
Due to the implementation of British Columbia Instrument 51-509
on September 30, 2008 by the British Columbia Securities Commission, we have
been deemed to be a British Columbia based reporting issuer. As such, we are
required to file certain information and documents at
www.sedar.com
.
Effective September 25, 2009, we effected a one (1) for two (2)
share consolidation of our authorized and issued and outstanding common stock.
As a result, our authorized capital decreased from 75,000,000 shares of common
stock with a par value of $0.001 to 37,500,000 shares of common stock with a par
value of $0.001 and our issued and outstanding shares decreased from 29,305,480
shares of common stock to 14,652,740 shares of common stock. The consolidation
became effective with the Over-the-Counter Bulletin Board at the opening for
trading on September 25, 2009 under the new stock symbol
GLCP
. Our new
CUSIP number at that time was
38079Q207
.
On February 8, 2010, the Company changed its name from Golden
Aria Corp. to Enertopia Corp. Our new CUSIP number is
29277Q1047
On
February 22, 2010, the Company increased its authorized share capital to
200,000,000 common shares.
On February 28, 2010, the Company entered into an Asset and
Share Purchase Agreement with Mr. Mark Snyder to acquire up to 20% ownership
interest of Global Solar Water Power Systems Inc. (GSWPS).
Effective March 26, 2010, Enertopia Corp. (the Company) had
its stock quotation under the symbol GLCP deleted from the OTC Bulletin Board.
The symbol was deleted for factors beyond the Companys control due to various
market makers electing to shift their orders from the OTCBB to the Pink OTC
Markets Inc. As a result of these market makers not providing a quote on the
OTCBB for four consecutive days the Company was deemed to be deficient in
maintaining a listing standard at the OTCBB pursuant to Rule 15c2-11. That
determination was made entirely without the Companys knowledge.
On April 7, 2010, FINRA confirmed the name change from Golden
Aria Corp. to Enertopia Corp., and approved the Companys new symbol as ENRT. On
February 5, 2010, the Companys shareholders approved an amendment to the
Companys articles of incorporation to change its name from Golden Aria Corp. to
Enertopia Corp. The name change was effected with the Nevada Secretary of State
on February 8, 2010.
On May 31, 2010, the Company closed a private placement
financing of 557,500 units at a price of $0.15 per unit for gross proceeds of
$83,625. Each unit consisted of one common share in the capital of the Company
and one non-transferable share purchase warrant, each full warrant entitling the
holder to purchase one additional common share in the capital of the Company
until May 31, 2012, at a purchase price of $0.30 per share.
On August 12, 2010, the Company was approved for listing on the
Canadian National Stock Exchange (CNSX). Trading date commenced on August 13,
2010 with the symbol
TOP.
On October 25, 2010 Company disposed of the Coteau Lake
interests for cash consideration of $100,000 plus an additional potential payout
which shall be based on a 10% profit interest on any and all productive wells
drilled on the property, up to $150,000. No receivable was recorded as the
future potential payout cannot be reasonably determined.
On January 31, 2011, the Company entered into a letter of
intent and paid $7,500 deposit to Wildhorse Copper Inc. and its wholly owned
subsidiary Wildhorse Copper (AZ) Inc. (collectively, the Optionors). On April
11, 2011, the Company signed a Mineral Purchase Option Agreement (Option
Agreement) with the Optionors respecting an option to earn a 100% interest,
subject to a 1% NSR capped to a maximum of $2,000,000 in a property known as the
Copper Hills property. The Copper Hills property is comprised of 56 located
mining claims covering a total of 1,150 acres located in New Mexico, USA. The
Optionors hold the Copper Hills property directly and indirectly through
property purchase agreements between the Optionors and third parties
(collectively, the Indirect Agreements). Pursuant to the Option Agreement the
Optionors have assigned the Indirect Agreements to the Company. In order to earn
the interest in the Copper Hills property, the Company is required to make
aggregate cash payments of $591,650 over an eight year period and issue an
aggregate of 1,000,000 shares of its common stock over a three year period. As
at August 31, 2013, the Company has issued 500,000 shares at price of $0.15 per
share and 150,000 shares at price of $0.10 per share to the Optionors and made
aggregate cash payment of $106,863 (August 31, 2012-$106,863); the Company has
expensed exploration costs of $143,680 (August 31, 2012-$143,680). On June 26,
2013, the Company announced the termination of its Option Agreement. the Company
had made aggregate cash payments of $106,863 and issued 500,000 shares at price
of $0.15 per share and 150,000 common shares at $0.10 per share to Wildhorse Copper Inc. On
June 26, 2013, the Company terminated its Option Agreement with Wildhorse Copper
Inc. on Copper Hills property.
On March 3, 2011, the Company closed a private placement of
8,729,000 units at a price of CAD$0.10 per unit for gross proceeds of
CAD$872,900, or US$893,993. Each unit consisted of one common share in the
capital of our company and one non-transferable share purchase warrant, each
full warrant entitling the holder to purchase one additional common share in the
capital of our company until March 3, 2013, subject to accelerated expiry as set
out in the warrant certificate, at a purchase price of CAD$0.20. As per the
terms of the Subscription Agreement, our company grants to the Subscribers a
participation right to participate in future offerings of our securities as to
their pro rata shares for a period of 12 months from the closing of the Private
Placement. We paid broker commissions of $48,930 in cash and issued 489,300
brokers warrants. Each full warrant entitled the holder to purchase one
additional common share in the capital of our company that expired on March 3,
2013, which was subject to accelerated expiry as set out in the warrant
certificate, at a purchase price of CAD$0.20.
On March 16, 2011, we entered into a debt settlement agreement
with an officer of our company, whereby we issued 78,125 shares of common stock
in connection with the settlement of $12,500 debt at a deemed price of $0.16 per
share pursuant to a consulting agreement. We recorded $12,422 in additional paid
in capital for the gain on the settlement of the debt.
On April 14, 2011, we held our Annual and Special Meeting of
Shareholders for the following purposes:
|
1.
|
To elect Robert McAllister, Dr. Gerald Carlson and Chris
Bunka as directors of the Company for the ensuing year.
|
|
|
|
|
2.
|
To ratify Chang Lee LLP, independent public accounting
firm for the fiscal year ending August 31, 2011, and to allow directors to
set the remuneration.
|
|
|
|
|
3.
|
To approve, ratify and confirm the consolidation of the
2007 Stock Option Plan and the 2010 Equity Compensation Plan into one plan
and approve the terms of this new plan, the 2011 Stock Option
Plan.
|
All proposals were approved by the shareholders. The proposals
are described in detail in our definitive proxy statement filed with the
Securities and Exchange Commission on March 9, 2011.
On April 27, 2011, we entered into a debt settlement agreement
with the President of our Company, who is a related party, in the amount of
$46,000, whereby $25,000 was settled by issuing common shares of 100,000, and
$21,000 was forgiven for Nil consideration. In connection with the debt
settlement, we recorded $100 in share capital and $45,900 in additional paid in
capital for the gain on the settlement of the debt.
On May 31, 2011, the Company settled the amount due to related
parties into two promissory notes of $80,320 (CAD$84,655) and $90,000. Both
promissory notes were unsecured, non-interest bearing and due on May 31, 2012 at
an imputed interest rate of 12% per annum upon the settlement. On April 27,
2011, we entered into debt settlement agreement with one of the holders, a
company controlled by the Chairman/CEO of the Company, whereby the Company
issued common shares of 360,000 to the holder, and the holder agreed to accept
the shares as full and final payment of the promissory note of $90,000. On the
same day, we entered into a debt settlement agreement with another holder, a
company controlled by the Chairman/CEO of our Company, whereby the holder agreed
to forgive the repayment of debt for Nil consideration. In connection with the
settlements and forgiveness of the above promissory notes, the Company recorded
$79,997and $77,415 in additional paid in capital for the gain on settlement of
debt, respectively.
On June 22, 2011, Change Lee LLP (Chang Lee) resigned as our
independent registered public accounting firm because Chang Lee was merged with
another company: MNP LLP (MNP). Most of the professional staff of Chang Lee
continued with MNP either as employees or partners of MNP and will continue
their practice with MNP.
On June 22, 2011, we engaged MNP as our independent registered
public accounting firm.
On July 19, 2011, the Company entered into a letter of intent
and paid US$15,000 deposit to Altar Resources. Subsequent to August 31, 2011, on
October 11, 2011, the Company signed a Mineral Purchase Option Agreement with Altar Resources with respect to an option to earn 100%
interest, subject to a 2.5% NSR in a property known as Mildred Peak. The mining
claims are in Arizona covering approximately 7,148 acres from Altar Resources
which holds the mining claims directly and indirectly through federal mining
claims and state mineral exploration leases; or, represented that it would hold
such claims in good standing at the time of closing a definitive agreement. The
Company is required to make aggregate cash payments of $881,000 over a five year
period and issue an aggregate of 1,000,000 shares of its common stock over a
four year period. As at February 28, 2013, the Company had made aggregate cash
payments of $124,980 (August 31, 2012-$84,980) and issued 100,000 shares at
price of $0.10 per share and 100,000 common shares at $0.06 per share to Altar
Resources; along with expensed incurred exploration costs of $13,380. On May 30,
2013, the Company terminated the Option Agreement and has written off $140,980
of capital costs.
On March 19, 2012, the Companys Board has appointed Dr. John
Thomas as Director and Mr. Tony Gilman and Dr. Stefan Kruse as Advisors of the
Company. The Company has granted additional 450,000 stock options to Directors
and Advisors of the Company. The exercise price of the stock options is $0.15,
of which are 225,000 options vest immediately, 225,000 options vest on August
15, 2012. The options expire March 19, 2017.
On April 10, 2012, Enertopia Corporation (Enertopia or the
Company) held its Annual and Special Meeting of Shareholders for the following
purposes:
|
1.
|
To elect Robert McAllister, Donald Findlay, Greg Dawson
and Chris Bunka as directors of the Company for the ensuing
year.
|
|
|
|
|
2.
|
To ratify MNP LLP, independent public accounting firm for
the fiscal year ending August 31, 2012, and to permit directors to set the
remuneration.
|
|
|
|
|
3.
|
To transact such other business as may properly come
before the Meeting.
|
All proposals were approved by the shareholders. The proposals
are described in detail in the Companys definitive proxy statement filed with
the Securities and Exchange Commission on March 13, 2012.
On April 10, 2012, the Company issued 93,750 common shares in
connection with the settlement of debt of $9,375 at a price of $0.10 per common
share pursuant to a consulting agreement.
On April 13, 2012, the Company closed an offering memorandum
placement of 2,080,000 units at a price of CAD$0.10 per unit for gross proceeds
of CAD$208,000, US$208,000. Each Unit consisted of one common share of the
Issuer and one common share purchase warrant. One warrant will be exercisable
into one further common share at a price of US$0.15 per warrant share for a
period of twelve months following closing; or at a price of US$0.20 per warrant
for the period that is twelve months plus one day to twenty-four months
following closing. The Company paid broker commissions of $14,420 in cash and
issued 144,200 brokers warrants in connection with the private placement.
On August 24, 2012, the Company closed the second tranche of an
offering memorandum placement of 160,000 units at a price of CAD$0.05 per unit
for gross proceeds of CAD$8,000 or US$8,000. Each warrant will be exercisable
into one further share at a price of US$0.10 per warrant share for a period of
twelve months following closing; or at a price of US$0.20 per warrant share for
a period that is twelve months and one day to thirty-six months following
closing. The Companys President participated in the private placement for
$4,000.00 dollars. The Company issued 16,000 brokers warrants in connection with
the private placement for broker commissions.
On September 28, 2012, the Company closed an offering
memorandum placement of 995,000 units at a price of CAD$0.05 per unit for gross
proceeds of CAD$49,750 or US$49,750. Each Unit consisted of one common share of
the Issuer and one common share purchase warrant. One warrant will be
exercisable into one further common share at a price of US$0.10 per warrant
share for a period of twelve months following closing; or at a price of US$0.20
per warrant for the period that is twelve months plus one day to twenty-four
months following closing. The Company issued 79,500 shares, 79,500 warrants and
79,500 broker warrants in connection with the private placement.
On October 24, 2012, the Company issued 100,000 common shares
in connection with Altar Resources, Mildred Peak property for an amount of
$6,000 at a price of $0.06.
On November 15, 2012, the Company closed an offering memorandum
placement of 1,013,000 units at a price of CAD$0.05 per unit for gross proceeds
of CAD$50,650 or US$50,650. Each Unit consisted of one common share of the
Issuer and one common share purchase warrant. One warrant will be exercisable
into one further common share at a price of US$0.10 per warrant share for a
period of twelve months following closing; or at a price of US$0.20 per warrant
for the period that is twelve months plus one day to twenty-four months
following closing. The Company issued 38,000 common shares, 101,300 units, and
101,300 broker warrants in connection with the private placement.
On March 1, 2013, the Company settled the debt incurred of
$16,000 from September 1, 2011 to February 28, 2013 for consulting fees with Mr.
Mark Snyder by issuing 160,000 restricted common shares of the Company at a
price of $0.10 per share.
On March 1, 2013, the Company settled the debt incurred of
$16,000 from September 1, 2011 to February 28, 2013 for consulting fees with Mr.
Mark Snyder by issuing 160,000 restricted common shares of the Company at a
price of $0.10 per share.
On May 30, 2013, the Company terminated its Option Agreement
with Altar Resources on Mildred Peak property.
On June 26, 2013, the Company terminated its Option Agreement
with Wildhorse Copper Inc. on Copper Hills property.
On September 17, 2013 we entered into an AMI Participation
Agreement with Downhole Energy LLC to participate in 100% gross interest and 75%
net revenue interest for drilling, completion and production of up to 100 oil
wells on certain oil and gas leases covering 2,924 in the historic field located
in Forest and Venango counties, Pennsylvania. On execution of this agreement we
issued 100,000 of our common shares to Downhole Energy LLC. The Company decided
not to continue with the agreement and wrote off the asset.
On October 4, 2013 we entered into a consulting agreement with
Olibri Acquisitions and issued 750,000 of our common shares to Olibri.
We entered into a Letter of Intent Agreement (LOI) on
November 1, 2013 with 0786521 BC Ltd. (also known as World of Marijuana
Productions Ltd.) (the Vendor) to acquire 51% of the issued and outstanding
capital stock of the Vendor. The Vendor is the owner, operator of a Medical
Marijuana operation located at 33420 Cardinal Street, Mission, British Columbia,
Canada. The LOI was not comprehensive and subject to the negotiation of a
definitive agreement. On the execution of the LOI, we issued 10,000,000 of our
common shares to the Vendor. The LOI was superseded by our joint venture
agreement with World of Marijuana Productions Ltd. dated January 16, 2014,
described below.
On November 5, 2013 we granted 675,000 stock options to
directors, officers, and consultant of our Company with an exercise price of
$0.06 vested immediately, expiring November 5, 2018.
On November 18, 2013, we granted 25,000 stock options to
consultant of our with an exercise price of $0.09 vested immediately, expiring
November 18, 2018.
On November 18, 2013, we entered into an investor relations
contract with Coal Harbour Communications Inc. The initial term of this
agreement shall begin on the date of execution of this Agreement and continue
for
two months
. Thereafter the agreement will continue on a
month-by-month basis pending cancelation by written notification with 30 days
notice. In consideration for the services the Company will pay the Provider a
one-time payment of two hundred thousand shares (200,000) of restricted common
stock in Enertopia Corporation. The stock will be issued in the name of Dale
Paruk for 100,000 shares and Neil Blake for 100,000 shares. In consideration of
the services provided, the Company shall pay. We also agree to pay to Coal
Harbour Communications a monthly fee of $5,000 payable on the 1st day of each
monthly period starting 60 days from the signing of the agreement and $500 per
month to cover expenses incurred on our Companys behalf. Any expenses above
$500 per month must be pre-approved.
On November 26, 2013, our Company closed the first tranche of a
private placement of 2,720,000 units at a price of CAD$0.05 per unit for gross
proceeds of CAD$136,000 ($136,000). Each warrant is exercisable into one further
share at a price of US$0.10 per warrant share for a period of thirty six month
following the close.
On November 29, 2013, our wholly-owned subsidiary, Target
Energy, Inc was discontinued and dissolved.
On December 23, 2013, we closed the final tranche of a private
placement of 2,528,000 units at a price of CAD$0.05 per unit for gross proceeds
of CAD$126,400 ($126,400). Each warrant is exercisable into one further share at
a price of $0.10 per warrant share for a period of thirty six months following
closing. We also paid a cash finders fee of $10,140 and 202,800 broker warrants
to Canaccord Genuity and Wolverton Securities that are exercisable into one
common share at a price of $0.10 that expire on December 23, 2016.
On January 1, 2014, we entered into a Social Media/Web
Marketing Agreement with Stuart Gray. The initial term of this agreement shall
begin on the date of execution of this Agreement and continue for three
months. In consideration for the services we will pay Stuart Gray a monthly
fee of $5,000. As additional compensation we issued 200,000 stock options to Mr.
Gray. The exercise price of the stock options is $0.075, with 100,000 stock
options vested immediately, 50,000 stock options vested 30 days after the grant
and 50,000 stock options vested 60 days after the grant, expiring January 1,
2019.
On January 13, 2014, we entered into a corporate development
agreement with Don Shaxon for an initial term of twelve months. Thereafter the
agreement continued on a month-by-month basis pending cancelation by written
notification with 30 days notice. In consideration for the services we paid to
Mr. Shaxon a signing stock bonus of 250,000 of our common shares, a one-time
cash bonus of $40,000, and a monthly fee of $3,500 plus $500 in monthly
expenses. Upon execution of the Agreement we also granted 250,000 stock options.
to Mr. Shaxon with an exercise price of $0.16, vesting immediately and expiring
January 13, 2019.
On January 16, 2014 we entered into a Joint Venture Agreement
with World of Marijuana Productions Ltd. (WOM) to acquire up to a 51%
ownership interest in a joint venture between WOM and our company. WOM was to
acquire a medical marijuana production licence from Health Canada to in order to
establish a medical marijuana production facility to be located at 33420
Cardinal Street, Mission, British Columbia.. The Joint Venture Agreement
superseded the Letter of Intent between our company and WOM dated November 1,
2013 (the "LOI"). Our company issued 16,000,000 common shares and paid a total
of $375,000 to WOM to acquire a 31% interest in the joint venture. Subsequent to
year end, on October 16, 2014 we entered into a termination and settlement
agreement, dated effective October 14, 2014, with WOM and Mathew Chadwick (the
Settlement Agreement), pursuant to which the parties have entered into mutual
releases, Mr. Chadwick has resigned from our board of directors and as an
officer of our company, and WOM has returned for cancellation 15,127,287 of our
common shares that had been issued to it. Given the foregoing, all relationships
between the parties, including but not limited to the joint venture, have been
terminated.
On January 31, 2014, we accepted and received gross proceeds of
CAD$40,500 (US$37,500), for the exercise of 350,000 stock options; 100,000 at
$0.075 each, 150,000 stock options at $0.10 each, and 100,000 stock options at
$0.15 each; into 350,000 common shares of our Company.
On January 31, 2014, we closed the first tranche of a private
placement of 4,292,000 units at a price of US$0.10 per unit for gross proceeds
of US$429,200. Each Unit consists of one share of our common stock and one half
(1/2) of one non-transferable common share purchase warrant Each whole warrant
is exercisable to purchase one common share at a price of US$0.15 per share for
a period of twenty four (24) months following closing. A cash finders fee
consisting of $29,616 and 296,160 full broker warrants that expire on January
31, 2016 with an exercise price of $0.15 was paid to Canaccord Genuity, Leede
Financial and Wolverton Securities.
On February 5, 2014, Ryan Foster joined our Company as an
advisor. We granted 50,000 stock options to Mr. Foster with an exercise price of
$0.35 per common share expiring February 5, 2019. 25,000 of the stock options
vested immediately and 25,000 vested on July 1, 2014.
On February 13, 2014, we closed the final tranche of a private
placement by issuing 12,938,000 units at a price of US$0.10 per unit for gross
proceeds of US$1,293,800. Each unit consists of one common share and one half
(1/2) of one non-transferable share purchase warrant with each whole warrant
exercisable into one common share at a price of US$0.15 per share for a period
of twenty four (24) months following closing. One director and one officer of
our Company participated in the final tranche for $30,000. A cash finders fee
consisting of $98,784; 8,000 common shares in lieu of $800 and 995,840 full
broker warrants that expire on February 13, 2016 with an exercise price of $0.15
was paid to Canaccord Genuity, Global Market Development LLC and Wolverton
Securities.
On February 13, 2014, 50,000 stock options were exercised at a
price of $0.06 by a Director and 50,000 stock options were exercised at a price
of $0.075 by a Consultant for net proceeds to our Company of CAD$7,050
(US$6,750) into 100,000 common shares of the Company.
On February 13, 2014, 541,500 warrants from previous private
placements were exercised into 541,500 common shares of our Company for net
proceeds of $101,100.
On February 27, 2014, 585,000 warrants from previous private
placements were exercised into 585,000 common shares of our Company for net
proceeds of $115,000.
On February 27, 2014, we signed a $50,000 12 month marketing
agreement with Agoracom payable in shares of our common stock. The first quarter
payment of $12,500 was paid with the issuance of 54,347 common shares of our
Company at a market price of $0.23 per share.
On February 28, 2014, we entered into a Joint Venture Agreement
with The Green Canvas Ltd.
("
GCL
") pursuant to which we may
acquire up to a 75% interest in the business of GCL, being the business of
legally producing, manufacturing, propagating, importing/exporting, testing,
researching and developing, and selling marijuana for medical purposes. We paid
$100,000 to the GCL upon execution of the agreement. Subsequently, we issued to
GCL an aggregate of 10,000,000 of our common shares at a price of $0.235 per
share; and paid to GCL the aggregate sum of $500,000, to earn a 49% interest in
GCLs business. With the exception of $113,400 payable to Wolverton Securities,
the full amount of the $500,000 is to be used by GCL to upgrade the its existing
medical marijuana production facility to meet the standards introduced by the
Marijuana for Medical Purposes Regulations (MMPR) administered by Health
Canada. This agreement has been terminated.
On March 5, 2014, our Company and our CEO and Director, Robert
McAllister, entered into a Joint Venture Agreement with Lexaria Corp. to jointly
source and develop business opportunities in the medical marijuana industry.
Pursuant to the terms of the agreement, Lexaria Corp. issued to our Company 1
million restricted common shares and issued 500,000 common shares to Mr.
McAllister for his participation as a key representative for the joint venture.
Additionally Lexaria agreed to issue to Mr. McAllister options to purchase
500,000 common shares of Lexaria in consideration for Mr. McAllisters
participation on the Lexaria Advisory Board.
On March 10, 2014, our Companys Board appointed Mathew
Chadwick as Senior Vice President of Marijuana Operations and our company
entered into a Management Agreement with Mr. Chadwick for his services. The
initial term of the agreement began on the date of execution of this agreement
and continued for six months. Thereafter the agreement continued on a
month-by-month basis until it was terminated on October 16, 2014 pursuant to a
termination and settlement agreement, dated effective October 14, 2014, with
World of Marijuana Productions Ltd. and Mr. Chadwick. We paid in total $125,000
to Mr. Chadwick pursuant to the Management Agreement. Mr. Chadwick resigned as a
director and officer of our Company on October 16, 2014.
On March 11, 2014, Robert Chadwick and Clayton Newbury joined
the Company as advisors and were paid a $1,000 honorarium each. Robert Chadwick
was issued a one-time 100,000 common shares of our Company. On March 11, 2014,
we granted 100,000 stock options to Robert Chadwick with an exercise price of
$0.68 per share expiring March 11, 2019. 50,000 of the stock options vested
immediately, and 50,000 vested on September 11, 2014. We also granted 100,000
options to Clayton Newbury on the same terms.
On March 11, 2014, as per the terms of the Joint Venture
Agreement dated January 16, 2014 with World of Marijuana Productions Ltd.
(
WOM
), our company made a payment of $200,000 and issued 1,000,000
common shares at a price of $0.60 per share to 0984329 B.C. LTD. As a result our
company acquired 31% of the Joint Venture business interest. We subsequently
relinquished the 31% interest pursuant to the Termination and Settlement
Agreement with WOM and Mathew Chadwick dated October 14, 2014. WOM returned for
cancellation 15,127,287 previously issued shares of our common stock in
consideration for our 31% interest.
On March 14, 2014, we signed a six month contract for $21,735
with The Money Channel to provide services for national television, internet and
radio media campaign.
On March 14, 2014, 815,310 warrants from previous private
placements were exercised into 815,310 common shares of our Company for net
proceeds of $163,062.
On March 14, 2014, we accepted and received gross proceeds from
a director of our Company of CAD$8,250 (US$7,500), for the exercise of 50,000
stock options at an exercise price of $0.15, into 50,000 common shares of our
Company.
On March 17, 2014, 1,548,000 warrants from previous private
placements were exercised into 1,548,000 common shares of our Company for net
proceeds of US$289,475.
On March 25, 2014, we accepted and received gross proceeds of
$67,750, for the exercise of 325,000 stock options at $0.06 to $0.25 each, into
325,000 common shares of our Company.
On March 25, 2014, 1,095,000 warrants from previous private
placements were exercised into 1,095,000 common shares of our Company for net
proceeds of US$114,250.
On March 26, 2014, our Board appointed Dr. Robert Melamede as
an Advisor to the Board of Directors. We paid to Dr. Melamede, an honorarium of
$2,500 for the first year of participation on our Advisory Board and issued
250,000 shares of our common stock. On March 26, 2014 we granted to Dr. Melamede
500,000 stock options with an exercise price of $0.70 and expiring March 26,
2019., 250,000 of the stock options vested immediately and the remaining 250,000
stock options vested on September 26, 2014, Subsequent to quarter end, Dr.
Robert Melamede is no longer an Advisor to the Board of Directors.
On April 1, 2014, we entered into a one year consulting
agreement with Kristian Dagsaan to provide controller services for CAD$3,000
(plus goods and services tax) per month. We also granted 100,000 fully vested
stock options with an exercise price of $0.86, expiring April 1, 2019. The
agreement was cancelled on August 31, 2014.
On April 1, 2014, we entered into a 90 day investor relations
contract for CAD $9,000 with Ken Faulkner. We also granted 100,000 fully vested
stock options to Mr. Faulkner with an exercise price of $0.86, expiring April 1,
2019.
On April 3, 2014, we entered into another 3 month Social
Media/Web Marketing Agreement with Stuart Gray. In consideration for the
services the Company we agreed to pay Mr. Gray a monthly fee of $5,000. Upon
execution of the Agreement, we issued 100,000 stock options to Mr. Gray with an
exercise price of $0.72, expiring on April 3, 2019. The agreement was terminated
on July 31, 2014.
On April 3, 2014, 1,293,500 warrants from previous private
placements were exercised into 1,293,500 common shares of our Company for net
proceeds of US$177,950.
On April 3, 2014, we accepted and received gross proceeds from
past consultant of our Company of US$1,500 for the exercise of 25,000 stock
options at an exercise price of $0.06, into 25,000 common shares of our Company.
On April 8, 2014, we granted 50,000 fully vested stock options
to a consultant of our Company, Taven White. The stock options are exercisable
at $0.50 per share and expire on April 8, 2019. This stock option agreement has
been cancelled.
On April 10, 2014, a Letter of Intent ("LOI") was signed by
Enertopia Corporation, or its wholly-owned subsidiary ("Enertopia") and Lexaria
Corp., or its wholly-owned subsidiary ("Lexaria") (collectively, the "Parties")
with regard to the ownership by Enertopia of a 51% interest in the business, and
the ownership by Lexaria of a 49% interest in the business of legally producing,
manufacturing, propagating, importing/exporting, testing, researching and
developing, and selling marijuana for medical purposes under the MMPR (the
"Business") Acquisition Structure. Whereby, Lexaria issued 500,000 common shares
to Enertopia. In accordance with the terms of a formal and definitive Agreement
to be entered into between Enertopia and Lexaria (the "Definitive Agreement"),
Enertopia shall own 51% ownership interest in the Business (the "Enertopia
Ownership") and Lexaria shall own 49% ownership interest in the Business (the
Lexaria Ownership). Within 10 days, Enertopia shall contribute $45,000 and
Lexaria shall contribute $55,000 to the Business. Upon the execution of this
LOI, Enertopia and Lexaria shall structure a joint venture for legally
producing, manufacturing, propagating, importing/exporting, testing, researching
and developing, and selling marijuana for medical purposes under the MMPR. At
such time the Parties will be deemed to have formed a joint venture for the
operation, management and further development of the Business (the "Joint
Venture"). Lexaria will pay 55% of all costs to earn its 49% net Ownership
Interest and Enertopia will pay 45% of all costs to earn its 51% Ownership
Interest. A total of 500,000 Definitive Agreement Shares shall be issued to
Enertopia, held in escrow (the "Escrow Shares") by Lexaria's solicitors until
such date as the License (as hereinafter defined) has been obtained by Enertopia (the
"Effective Date"). Upon occurrence of the Effective Date, the Escrow Shares will
be released from escrow. In the event the Effective Date does not occur within
12 months of the date of the Definitive Agreement (the "Execution Date"), the
Definitive Agreement Shares shall be cancelled and returned to treasury.
Subsequent to quarter end, this agreement has been terminated.
On April 10, 2014 a letter of intent, was executed on behalf of
a corporation to be incorporated by Lexaria Corp. and Enertopia
Corporation(Lessee) and Mr. Jeff Paikin of Ontario Inc. (Lessor) sets out the
Lessees and Lessors shared intent to enter into a lease agreement (the
Lease) for warehouse space (the Leased Premises) in the building located in
Ontario (the Building). The Company issued the 38,297 common shares at a
deemed price of $0.47 per the terms of the Letter of Intent to lease space in
Ontario. On August 1, 2014 the Company signed an extension to the Letter of
intent executed on April 10, 2014 on behalf of a corporation to be incorporated
by Lexaria Corp. and Enertopia Corporation(Lessee) and Mr. Jeff Paikin of
1475714 Ontario Inc. (Lessor) sets out the Lessees and Lessors shared intent
to enter into a lease agreement (the Lease) for warehouse space (the Leased
Premises) in the building located at Burlington, Ontario (the Building). On
August 5, 2014, as per the terms of the extension, 118,416 common shares of the
Company were issued at a deemed price of $0.19 per share. This agreement was not
renewed and terminated.
On April 14, 2014, the Company appointed Mr. Jeff Paikin to its
Advisory Board for a period of not less than one year, but to be determined by
certain performance thresholds described in the letter. Upon signing of the
letter of acceptance the Company issued 90,000 common shares at a deemed price
of $0.34. Based on the milestones listed in the letter, Mr. Paikin can be
eligible to receive up to a total of 472,500 common shares of the Company.
Consulting agreement amended on June 18, 2014, Mr. Paikin can be eligible to
receive up to a total of 1,350,000 common shares of the Company. Based on the
milestones listed in the amended contract, the Company issued Mr. Paikin 135,000
common shares at a deemed price of $0.14 on July 14, 2014. On February 4, 2015,
Mr. Paikin resigned as an Advisor to the Board and the agreement was terminated.
On April 17, 2014, our Company accepted and received gross
proceeds from a director of CAD$8,475 (US$7,500), for the exercise of 50,000
stock options at $0.15 into 50,000 common shares of our Company.
On April 17, 2014, 651,045 warrants from previous private
placements were exercised into 651,045 common shares of our Company for net
proceeds of $110,209.
On April 24, 2014 our Company entered into a one year
consulting contract with Clark Kent as Media Coordinator for a monthly fee of
CAD$2,250 plus GST. We issued 90,000 common shares to the consultant at a deemed
price of $0.34. Based on the milestones listed in the contract, Mr. Kent can be
eligible to receive up to a total of 472,500 common shares of our Company. On
June 18, 2014, the consulting agreement was amended so that Mr. Kent can be
eligible to receive up to a total of 1,350,000 common shares of our Company.
Based on achievement of the milestones listed in the amended contract, we issued
to Mr. Kent 135,000 common shares at a deemed price of $0.14 on July 14, 2014.
This agreement was terminated on February 4, 2015.
On April 24, 2014 we entered into a one year consulting
contract with Don Shaxon as Ontario Operations Manager for a monthly fee of
CAD$3,375 plus GST. Upon signing of the contract we issued to Mr. Shaxon 90,000
common shares at a deemed price of $0.34. Based on the milestones listed in the
contract, Mr. Shaxon can be eligible to receive up to a total of 472,500 common
shares of our Company. We amended the consulting agreement on June 18, 2014,
following which Mr. Shaxon became eligible to receive up to a total of 1,350,000
common shares of our Company. Based on achievement of the milestones listed in
the amended contract, we issued to Mr. Shaxon 135,000 common shares at a deemed
price of $0.14 on July 14, 2014. This agreement was not renewed and terminated.
On April 24, 2014 we entered into a one year consulting
contract with 490072 Ontario Ltd. operating as HEC Group, for the services of
Greg Boone as Human Resources Manager. Upon signing of the contract we issued
90,000 common shares at a deemed price of $0.34. Based on the milestones listed
in the contract, Mr. Boone or his company can be eligible to receive up to a
total of 472,500 common shares of our Company. We amended the agreement on June
18, 2014, further to which Mr. Boone became eligible to receive up to a total of
1,350,000 common shares of our Company. Based on achievement of the milestones
listed in the amended contract, the Company issued Mr. Boone 135,000 common
shares at a deemed price of $0.14 on July 14, 2014. This agreement was
terminated on February 4, 2015.
On April 24, 2014 we entered into a one year consulting
contract with Jason Springett as Master Grower for Ontario Operations for a
monthly fee of $3,375 plus GST. Upon signing of the contract we issued 90,000
common shares at a deemed price of $0.34. Based on the milestones listed in the
contract, Mr. Springett was eligible to receive up to a total of 472,500 common
shares of the Company. We amended the agreement on June 18, 2014 further to
which Mr. Springett became eligible to receive up to a total of 1,350,000 common
shares of our Company. Based on achievement of the milestones listed in the
amended contract, we issued Mr. Springett 135,000 common shares at a deemed
price of $0.14 on July 14, 2014. This agreement was not renewed and terminated.
On April 24, 2014 we entered into a one year consulting
contract with 2342878 Ontario Inc. for the services of Chris Hornung as
Assistant Operations Manager. Upon signing of the contract we issued 90,000
common shares to the consultant at a deemed price of $0.34. Subject to
achievement of the milestones listed in the contract, Mr. Hornung or his company
were eligible to receive up to a total of 472,500 common shares of our Company.
Mr. Hornung resigned on July 14, 2014 prior to the accrual of additional
compensation. The 90,000 common shares of the Company that were issued have been
returned back to treasury on September 24, 2014.
On April 30, 2014, 200,000 warrants from previous private
placements were exercised into 200,000 common shares of our Company for net
proceeds of $40,000.
On May 3, 2014 we entered into a one year consulting contract
with Bmullan and Associates wholly owned company by Brian Mullan as Security
Consultant. Upon signing of the contract we issued to the consultant 45,000
common shares at a deemed price of $0.28. Subject to achievement of the
milestones listed in the contract, Mr. Mullan or his company are be eligible to
receive up to a total of 225,000 common shares of our Company. Subsequently, we
issued an additional 45,000 common shares to the consultant at a deemed price of
$0.14 on July 14, 2014. This agreement was terminated on February 4, 2015.
On May 28, 2014, our company and Lexaria entered into a
definitive agreement to develop a joint business for the production,
manufacture, propagation, import/export, testing, research and development of
marijuana in the Province of Ontario under the MMPR, Pursuant to the Agreement,
ownership, revenues, and liability related to the Joint Venture is 51% to
Enertopia and 49% to Lexaria. Expenses incurred by the joint venture shall be
allocated 45% to Enertopia and 55% to Lexaria. Enertopia shall be responsible
for management of the joint venture for as long as it maintains majority
ownership. To date, Lexaria and Enertopia have contributed $55,000 and $45,000
to the joint venture, respectively. The joint venture has identified a
production location in Burlington, Ontario and received municipal approval for
the site in July, 2014. We intend to engage an architect to design the
production facility upon acceptance of our application. Construction is
anticipated to cost approximately $3,000,000; Enertopia will be responsible for
$1,350,000 of this cost. The joint venture is unable to estimate at this time
when a production license might be granted by Health Canada, however it is
seeking assurances from Health Canada prior to commencement of construction.
This agreement was terminated.
On May 29, 2014, we accepted and received gross proceeds of
$20,000 for the exercise of 200,000 warrants at $0.10 each into 200,000 common
shares of our Company.
On June 2, 2014, we signed a 30 day contract for $10,000 with
TDM Financial to provide services for original video production, original
coverage, network placement of video and article, article and video syndication,
email distribution, and reporting.
On June 9, 2014, Pursuant to our 12 month marketing agreement
with Agoracom dated February 27, 2014, we made a second quarter payment to
Agoracom of $12,500 plus GST paid by the issuance of 72,917 common shares of the
Company at a market price of $0.18 per share.
On July 1, 2014, we entered into a one year services agreement
with TDM Financial for $120,000 payable in common shares of our Company. TDM
Financial will provide marketing solutions and strategies to our Company. Upon
the signing of the contract with TDM Financial, we issued 750,000 common stock
of our Company at a deemed price of $0.16.
On July 23, 2014, 252,000 warrants from previous private
placements were exercised into 252,000 common shares of our Company for net
proceeds of $25,200.
On August 1, 2014 we entered into a three month Investor
Relations and Marketing Agreement with Neil Blake with a monthly fee of
CAD$2,500.
On September 18, 2014, we entered into a contract with our
joint venture partner Lexaria Corp., and Maureen McGrath pursuant to which Ms.
McGrath will lead the National Medical Marijuana Awareness and Outreach
Strategy, a public awareness program jointly administered by Lexaria and our
company.
On October 16, 2014 we entered into a termination and
settlement agreement, dated effective October 14, 2014, with World of Marihuana
Productions Ltd. ()WOM and Mathew Chadwick (WOMs representative and our
former director), pursuant to which we relinquished our 31% interest in the
joint venture and exchanged mutual releases with WOM and Mr. Chadwick. Mr.
Chadwick resigned from our board of directors and as an officer of our company,
and WOM returned for cancellation 15,127,287 of our common shares that had been
issued to it. Given the foregoing, all relationships between the parties,
including but not limited to the joint venture, have been terminated. No
production license under the MMPR had been awarded or was forthcoming at the
time of termination.
On November 3, 2014, the Company granted 2,100,000 stock
options to directors, officers and consultants of the Company, vesting
immediately with an exercise price of $0.10, expiring November 3, 2019.
On November 18, 2014, the Company granted 100,000 stock options
to a consultant of the Company, vesting immediately with an exercise price of
$0.10, expiring November 18, 2019.
On January 30, 2015, we closed the first tranche of a private
placement of 1,665,000 units at a price of CAD$0.06 per unit for gross proceeds
of US$79,920 (CAD$99,900). Each Unit consists of one common share of the Company
and full non-transferable Share purchase warrant. Each Warrant will be
exercisable into one further Share at a price of US$0.10 per Warrant Share at
any time until the close of business on the day which is 24 months from the date
of issue of the Warrant, and thereafter at a price of US$0.15 per Warrant Share
at any time until the close of business on the day which is 36 months from the
date of issue of the Warrant.
On February 6, 2015, the Companys Board has appointed Bal
Bhullar as a Director of the Company. Ms. Bhullar has been and continues to be
the Chief Financial Officer of the Company since October 9, 2009.
February 6, 2015, the Board of Directors accepted the
resignation of John Thomas as Director of the Company.
On February 9, 2014, we entered into a one year contract with
Maureen McGrath/McGrath Group as Lead Medical Strategist, with a monthly fee of
CAD$3,000.
On February 9, 2015, Enertopia announced the launch of a new
product line V-Love
TM
for womens sexual pleasure. V-Love
TM
is a brand new water based, silky smooth fragrance free personal
lubricant and intimate gel especially designed for women.
On March 12, 2015, the Company closed its final tranche of a
private placement of 590,000 units at a price of CAD$0.06 per unit for gross
proceeds of CAD$35,400. Each unit consists
of one common share of the
Company and one non-transferable share purchase warrant, each full warrant
entitling the holder to purchase one additional common share of the Company for
a period of 36 months from the date of issuance, at a purchase price of US$0.10
during the first 24 months and at US$0.15 after 24 months. A cash finders fee
of CAD$2,832 and 47,200 full broker warrants that expire on March 12, 2018 was
paid to Canaccord Genuity.
In May, 2015, V-Love
TM
was available to the retail
market for purchase in stores and at various events.
On June 11, 2015, we entered into a mutual Termination
Agreement with The Green Canvas Ltd. pursuant to which we terminated our
relationship and relinquished our 49% interest in the joint venture to establish
a medical marijuana production facility near Regina, Saskatchewan. In
consideration of the termination, The Green Canvas returned for cancellation
6,400,000 shares of our common stock previously issued to GCL.
On June 11, 2015, we entered into a Letter of Intent dated June
10, 2015 with Shaxon Enterprises Ltd. to sell our 51% interest in our Burlington
Joint Venture with Lexaria Corp., including our interest in MMPR application
number 10QMM0610 for the proposed Burlington, Ontario production facility. The
sale would be completed by the sale of our wholly owned subsidiary, Thor Pharma
Corp.
Subsequent to the LOI with Shaxon Enterprises Ltd., the
Burlington Joint Venture between Enertopia and Lexaria which was entered into on
May 28, 2014 was terminated due to the pending sale of the project. As a result
of the termination, 500,000 restricted and escrowed common shares of Lexaria
issued to our Company at a deemed price of $0.40 will be returned to treasury
and cancelled. The Enertopia and Lexaria Master Joint Venture Agreement entered
into on March 5, 2014 is still effective and governs the relationship between
the parties.
On June 26, 2015, we signed a Definitive agreement to sell our
wholly owned subsidiary, Thor Pharma Corp along with the MMPR application number
10MMPR0610. The Burlington MMPR license application will continue in the
application process under new ownership. Pursuant to the agreement, we received
a non-refundable $10,000 deposit and are entitled to receive up to $1,500,000 in
milestone payments upon the Burlington facility becoming licensed under the
MMPR. These monies would be split equally with Lexaria Corp. Notwithstanding the
foregoing, we can neither guarantee nor provide a meaningful time estimate
regarding the potential grant of a production license for the Burlington
facility.
On June 29, 2015, we that announced V-Love
TM
became
available at London Drugs Limited stores. V-Love
TM
is currently
available at London Drugs stores across Western Canada in the provinces of
British Columbia, Alberta, Saskatchewan and Manitoba.
On July 7, 2015 we announced that V-Love
TM
became
available for purchase online in Canada at Amazon.ca.
On July 30, 2015 we announced the launch of V-Love.co, our
product website for V-Love
TM
.
On October 23, 2015
,
the Companys Board has appointed
Kevin Brown as a Director of the Company and Victor Lebouthillier as an advisor
to the Board of Directors.
On October 23, 2015, the Board of Directors accepted the
resignation of Donald Findlay as Director of the Company.
On October 23, 2015, we granted 1,850,000 stock options to
Directors, Executives and Consultants of the Company. The exercise price of the
stock options is $0.05, vested immediately, expiring October 23, 2020.
On December 16, 2015, we extended two classes of warrants by
two years with all other terms and conditions remaining the same. We approved
the expiry extension from January 31, 2016 till January 31, 2018 on 2,167,160
warrants that remain outstanding from the non-brokered private placement that
closed on January 31, 2014. The Company approved the expiry extension from
February 13, 2016 till February 13, 2018 on 7,227,340 warrants that remain
outstanding from the non-brokered private placement that closed on February 13,
2014.
On February 4, 2016, the Companys Board has appointed Olivier
Vincent as an Advisor the Board of Directors and a consultant for a term of one
year and granted 100,000 stock options to Olivier Vincent. The exercise price of
the stock options is $0.05, vested immediately, expiring February 4, 2021. We
issued 100,000 common shares at a price of $0.05 per share on exercise of these
options.
On March 9, 2016
,
we closed a binding Letter Of Intent
to acquire 100% of an established profitable private nutritional
vitamin/supplement company. The private nutritional vitamin/supplement company
has been in business for over 5 years showing good positive cash flows. All
products are manufactured by a GMP, NSF, FDA approved manufacturer in the United
States. Enertopia has agreed subject to further due diligence, review of
financials and financing to a total amount of $350,000 for the acquisition, with
$300,000 due on the signing of the Definitive Purchase Agreement. The Definitive
Purchase Agreement is expected to be completed before the end of April. The
Company did not further pursue this.
On April 21, 2016
,
Enertopia has signed a binding letter
of intent with a to enter into negotiations to effect the optional acquisition
of certain placer mining claims (the Claims) in Nevada covering approximately
2,560 acres from S P W Inc. S P W Inc. holds the Claims directly (Underlying
Owner). Upon the closing date of the transaction (the Effective
Date) S P W Inc. will have the right to transfer, option, sell or assign
the Claims to Enertopia. The Placer mining claims and any underlying agreements
will be acquired by Enertopia through a mineral property option agreement, an
assignment agreement or an asset acquisition (the Transaction).
On May 12, 2016 Enertopia has signed the Definitive Agreement
with the Vendor respecting the option to purchase a 100% interest in
approximately 2,560 acres of placer mining claims in Churchill, Lander and Nye
Counties Nevada, USA. These placer mining claims are subject to a 1.5%
NSR from commercial production with the Company able to buy back the NSR at the
rate of $500,000 per 0.5% NSR.
On May 20, 2016, Enertopia closed the first tranche of a
private placement of 6,413,333 units at a price of CAD$0.015 per unit for gross
proceeds of USD$74,074 (CAD$96,200). Each Unit consists of one common share of
the Company and full non-transferable Share purchase warrant (each whole
warrant, a Warrant). Each Warrant will be exercisable into one further Share
(a Warrant Share) at a price of US$0.05 per Warrant Share at any time until
the close of business on the day which is 18
months from the date of
issue of the Warrant, and thereafter at a price of US$0.10 per Warrant Share at
any time until the close of business on the day which is 36
months from
the date of issue of the Warrant. A cash finders fee of USD$5,421 (CAD$7,040)
and 469,333 full broker warrants that expire May 20, 2019 was paid to Canaccord
Genuity and Haywood.
On June 8, 2016, Enertopia closed its final tranche of a
private placement of 3,016,667 units a price of CAD$0.015 per unit for gross
proceeds of US$34,390 (CAD$45,250). Each Unit consists of one common share of
the Company and full non-transferable Share purchase warrant (each whole
warrant, a Warrant). Each Warrant will be exercisable into one further Share
(a Warrant Share) at a price of US$0.05 per Warrant Share at any time until
the close of business on the day which is 18
months from the date of
issue of the Warrant, and thereafter at a price of US$0.10 per Warrant Share at
any time until the close of business on the day which is 36
months from
the date of issue of the Warrant. A cash finders fee of USD$2,508 (CAD$3,300)
and 286,666 full broker warrants that expire June 8, 2019 was paid to Canaccord
Genuity, Leede Jones Gable, PI Financial and Mackie Research.
On August 9, 2016, we closed the first tranche of a private
placement of 4,500,000 units at a price of CAD$0.035 per unit for gross proceeds
of USD$120,078 (CAD$157,500). Each unit consists of one common share of our
Company and one non-transferable share purchase warrant, each full warrant
entitling the holder to purchase one additional common share of our Company for
a period of 24 months from the date of issuance, at a purchase price of
USD$0.07.
On August 10, 2016
,
we retained a private consulting
firm to assist with mergers, acquisitions and market awareness for a 12 month
contract. The consulting firm operates a resource holding company that has been
active in acquiring out of favor mining assets over the past several years. It
also provides breaking news, commentary and analysis on listed companies. We
engaged and paid the consulting firm USD$75,000.
On August 15, 2016 binding Letter of Intent was signed by us
and Genesis Water Technologies, Inc.
("
GWT
") with regard to the
acquisition by Enertopia (the "Acquisition") of the exclusive worldwide
licensing rights (the "Licensing
Rights") of all of the technology used
in the process of recovering and extraction of battery grade lithium carbonate
powder Li2CO3 grading 99.5% or higher purity from brine solutions (the
"Technology") and covered under patent pending process #XXXXXX (the "Pending
Patent"). On August 15, 2016, we issued 250,000 common shares at an exercise
price of $0.05 per share as per the binding LOI signed with Genesis Water
Technologies Inc.
Our Current Business
The Company is diverse in its pursuit of business opportunities
in the resource sector.
On
September 19, 2016
, we entered into a one year
Investor Relations Consulting agreement with Duncan McKay. Based on the terms of
the agreement, Mr. McKay can earn up to a maximum of 10% commissions on capital
raised. We issued 800,000 stock options with an exercise price of $0.07.
On
September 23, 2016
, we closed the final tranche of a
private placement of 3,858,571 units at a price of CAD$0.035 per unit for gross
proceeds of CAD$135,050. Each unit consists
of one common share of our
Company and one non-transferable share purchase warrant, each full warrant
entitling the holder to purchase one additional common share of our Company for
a period of 24 months from the date of issuance, at a purchase price of US$0.07.
A cash finders fee of CAD$3,300 and 286,666 full broker warrants that expire
June 8, 2019 was paid to Canaccord Genuity and Leede Jones Gable.
On
October 7, 2016
, we issued 175,000 common shares of
our Company and paid $5,000 to comply with the Definitive Agreement signed May
12, 2016.
On
December 6, 2016,
we signed a Definitive Commercial
Agreement with Genesis Water Technologies with regard to the acquisition of
exclusive licensing rights of the technology as outlined in the agreement.
On
January 20, 2017
, the Company closed the first
tranche of a private placement of 1,000,000 units at a price of CAD$0.04 per
unit for gross proceeds of CAD $40,000. Each unit consists of one common share
of the Company and one-nontransferable share purchase warrant, each full warrant
entitling the holder to purchase one additional common share of the Company for
a period of 24 months from the date of issuance, at a purchase price of $0.06. A
cash finders fee of CAD$800 and 20,000 full broker warrants that expire January
20, 2019 was paid to Leede Jones Gable Inc.
On
January 20, 2017
, the Company granted 1,535,000 stock
options to directors, officers and consultant of the Company with an exercise
price of $0.07 vested immediately, expiring January 20, 2022.
On
January 31, 2017
, the Company granted 1,500,000 stock
options to consultant of the Company with an exercise price of $0.07 vested
immediately, expiring January 31, 2022.
On
February 28, 2017
, the Company closed the first
tranche of a private placement of 4,250,000 units at a price of CAD$0.04 per
unit for gross proceeds of CAD $170,000. Each unit consists of one common share
of the Company and one-nontransferable share purchase warrant, each full warrant
entitling the holder to purchase one additional common share of the Company for
a period of 24 months from the date of issuance, at a purchase price of $0.06. A
cash finders fee of CAD$11,100 and 227,500 full broker warrants that expire
February 28, 2019 was paid to Leede Jones Gable Inc., Canaccord Genuity and
Duncan McKay.
On
February 28, 2017
, the Company signed a Letter of
Engagement with Adam Mogil and issued 1,000,000 warrant options to convert to
1,000,000 common shares to Adam Mogil to provide corporate services. The
warrants have an exercise price of $0.09 and expire August 28, 2017.
Mineral Property
Lithium Property
Enertopia (Optionee) has signed the Definitive Agreement on May
12,
2016 with the Vendor respecting the option to purchase a 100%
interest in approximately 2,560 acres of placer mining claims in Churchill,
Lander and Nye Counties Nevada, USA. These placer mining claims are subject to a
1.5% NSR from commercial production with the Company able to buy back the NSR at
the rate of $500,000 per 0.5% NSR.
Purchase Price for the Claims
The consideration payable by Enertopia to the Optionor.
pursuant to this Offer shall consist of:
|
(a)
|
paying $7,000 on signing the Offer; (paid)
|
|
|
|
|
(b)
|
paying $12,000 on signing of the definitive agreement
(the Agreement) and issuing 3,500,000 common shares in the capital stock
of Enertopia as soon as practicable following the execution of the
Agreement, (paid)
|
|
|
|
|
(c)
|
paying an optional $12,000 on or before the six month
anniversary of the definitive agreement (the Agreement), (paid and
issued 175,000 common shares of the Company)
|
|
|
|
|
(b)
|
paying an optional $22,500 on or before the one year
anniversary of the definitive agreement (the Agreement),
|
|
|
|
|
(d)
|
issuing additional common shares in the capital of the
Optionee, as constituted on the date hereof, to be issued to the Optionor
pursuant to the discovery of a Lithium enriched brine with an average
300ppm Li over 100 foot vertical interval in the enriched lithium brine in
the Central Nevada Brine Project. 1,000,000 Bonus Shares will be issued
per each successful property discovery meeting the foregoing criteria up
to a maximum 3,000,000 Bonus Shares.
|
NSR
There is a 1.5% Net Smelter Return
(NSR) payable on all Placer mining claims from commercial production to be
paid according to the terms and conditions as set forth in the Transaction
Documents. The NSR can be re purchased for $500,000 per every 0.5% .
Central Nevada Lithium Brine Project
Concessions
BIG SMOKY VALLEY, NYE COUNTY
NEVADA
|
SERIAL
|
|
|
|
CLAIM
NAME
|
NUMBER
|
LEAD
FILE
|
CLAIMANT
|
DATE
|
BSV1
|
NMC1132074
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV2
|
NMC1132075
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV3
|
NMC1132076
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV4
|
NMC1132077
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV5
|
NMC1132078
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV6
|
NMC1132079
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV7
|
NMC1132080
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV8
|
NMC1132081
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV9
|
NMC1132082
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV10
|
NMC1132083
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV11
|
NMC1132084
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV12
|
NMC1132085
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV13
|
NMC1132086
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV14
|
NMC1132087
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV15
|
NMC1132088
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV16
|
NMC1132089
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV17
|
NMC1132090
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV18
|
NMC1132091
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV19
|
NMC1132092
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV20
|
NMC1132093
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV21
|
NMC1132094
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV22
|
NMC1132095
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV23
|
NMC1132096
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV24
|
NMC1132097
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV25
|
NMC1132098
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV26
|
NMC1132099
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV27
|
NMC1132100
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV28
|
NMC1132101
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV29
|
NMC1132102
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV30
|
NMC1132103
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV31
|
NMC1132104
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV32
|
NMC1132105
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV33
|
NMC1132106
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV34
|
NMC1132107
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV35
|
NMC1132108
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV36
|
NMC1132109
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV37
|
NMC1132110
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV38
|
NMC1132111
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV39
|
NMC1132112
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV40
|
NMC1132113
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV41
|
NMC1132114
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV42
|
NMC1132115
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV43
|
NMC1132116
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV44
|
NMC1132117
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV45
|
NMC1132118
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV46
|
NMC1132119
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV47
|
NMC1132120
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV48
|
NMC1132121
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV49
|
NMC1132122
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV50
|
NMC1132123
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV51
|
NMC1132124
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV52
|
NMC1132125
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV53
|
NMC1132126
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV54
|
NMC1132127
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV55
|
NMC1132128
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV56
|
NMC1132129
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV57
|
NMC1132130
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV58
|
NMC1132131
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV59
|
NMC1132132
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV60
|
NMC1132133
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV61
|
NMC1132134
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV62
|
NMC1132135
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV63
|
NMC1132136
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
BSV64
|
NMC1132137
|
NMC1132074
|
ENERTOPIA
|
09/03/2016
|
EDWARDS CREEK VALLEY, CHURCHILL COUNTY NEVADA
CLAIM
|
SERIAL
|
|
|
|
NAME
|
NUMBER
|
LEAD
FILE
|
CLAIMANT
|
DATE
|
|
|
|
|
|
ECV1
|
NMC1132138
|
NMC1132138
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
ECV2
|
NMC1132139
|
NMC1132138
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
ECV3
|
NMC1132140
|
NMC1132138
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
ECV4
|
NMC1132141
|
NMC1132138
|
BRANDON ROBERT
|
09/04/2016
|
SMITH CREEK VALLEY, LANDER COUNTY NEVADA
CLAIM
|
SERIAL
|
|
|
|
NAME
|
NUMBER
|
LEAD
FILE
|
CLAIMANT
|
DATE
|
|
|
|
|
|
SCV1
|
NMC1132142
|
NMC1132142
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
SCV2
|
NMC1132143
|
NMC1132142
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
SCV3
|
NMC1132144
|
NMC1132142
|
BRANDON ROBERT
|
09/04/2016
|
|
|
|
|
|
SCV4
|
NMC1132145
|
NMC1132142
|
BRANDON ROBERT
|
09/04/2016
|
LITHIUM TECHNOLOGY
On August 15, 2016, a binding Letter of Intent was signed by
Enertopia and Genesis Water Technologies, Inc.
("
GWT
") with regard
to the acquisition by Enertopia (the "
Acquisition
") of the exclusive
worldwide licensing rights (the "
Licensing Rights
") by Enertopia of all
of the technology used in the process of recovering and extraction of battery
grade lithium carbonate powder Li2CO3 grading 99.5% or higher purity from brine
solutions (the "
Technology
") and covered under patent pending process
#XXXXXX (the "
Pending Patent
").
On
December 6, 2016
a Definitive Commercial Agreement
signed by Enertopia and Genesis Water Technologies, Inc.
with regard to
the acquisition by Enertopia of the exclusive licensing rights (the
"
Licensing Rights
") by Enertopia of all of the technology used in the
process of recovering and extraction of battery grade lithium carbonate powder
Li2CO3 grading 99.5% or higher purity from brine solutions (the
"
Technology
") and covered under patent pending process #XXXXXX (the
"
Pending Patent
").
In accordance with the terms of the formal Definitive
Commercial Agreement (the
Definitive Agreement
) the following are key
points are as follows:
|
e)
|
Enertopia to pay within 30 days to GWT $10,000 for the
bench testing of four lithium brine samples to confirm the June 2016
feasibility report. Upon successful independent 3
rd
party lab
testing of the bench test results, final location will be confirmed for
permitting and construction of 50 gpm test pilot facility which will take
approximately three months to build.
|
|
f)
|
Upon successful test pilot facility results, start the
construction of commercial Lithium recovery production facility.
|
|
g)
|
GWT has granted Enertopia exclusive rights and
relicensing rights to the usage of GWTs patent pending technology
covering United States of America, Argentina, Bolivia and Chile as per the
Commercialization Agreement in return for 10 per cent of net sales royalty
payments for battery grade Lithium Carbonate Li2CO3 produced.
|
|
h)
|
In order to maintain its exclusive rights, Enertopia will
need to make the following minimal payments to GWT on the anniversary of
signing the definitive agreement:
|
|
a.
|
On or before December 6, 2017, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$50,000;
|
|
b.
|
On or before December 6, 2018, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$150,000;
|
|
c.
|
On or before December 6, 2019, the greater of 10 per cent
of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or
$200,000;
|
|
d.
|
For 2019 to 2023, the greater of 10 per cent of Enertopia
net Lithium Carbonate Li2CO3 sales from brine sources or $200,000 per
annum.
|
|
e.
|
Right of first refusal to renew exclusive rights and
relicensing rights for another 10 years after the first seven year
licensing period on the same net sales terms as those of 2023 or $250,000
per annum.
|
Investments
We currently hold the following investment interests:
Equity Investment in Pro Eco Energy, Inc.
On April 21, 2008, we announced that we had made a $45,000
investment to acquire 8.25% of the equity of Pro Eco Energy USA Ltd., a clean
tech energy company involved in designing, developing and installing solar
energy solutions for commercial and residential customers. During fiscal year
2014, we entered into an agreement to sell our 8.25% ownership in Pro Eco Energy for $40,000 to Western
Standard Energy Corp. (now Dominovas Energy) The purchase price was to be
payable as follows: a) $10,000 on December 02, 2013; b) $10,000 on or before
December 31, 2013; c) $10,000 on or before January 31, 2014; d) $10,000 on or
before February 28, 2014. As at August 31, 2015, we had collected $10,000 of the
$40,000 purchase price. As at August 31, 2015, we have received back 600,000 of
the 900,000 Pro Eco Energy shares from Western Standard Energy Corp. and the
accounts receivable has been settled upon the return of the shares. The Company
has no significant influence in Pro Eco Energy.
The value of Pro Eco Energys shares have been written to $1 by
management during the year ended August 31, 2016 based on the managements
assessment of Pro Eco Energys current operations.
On February 28, 2017, Pro Eco Energy announced it is closing
its business. The Company will write down the asset to nil.
Equity Investment in Global Solar Water Power Systems
Inc.
In November 2012, the Company had a valuation report completed
on GSWPS by RWE Growth Partners Inc. As a result, the Companys long-term
investment in GSWPS has been written down to $68,500 as at August 31, 2012.
During the August 31, 2013 fiscal year end, based on the managements assessment
of GSWPSs current operations, the Company decided to write down long-term
investment in GSWPS to $1.
Summary
The continuation of our business is dependent upon obtaining
further financing, a successful programs of development, and, finally, achieving
a profitable level of operations. The issuance of additional equity securities
by us could result in a significant dilution in the equity interests of our
current stockholders. Obtaining commercial loans, assuming those loans would be
available, will increase our liabilities and future cash commitments.
There are no assurances that we will be able to obtain further
funds required for our continued operations. As noted herein, we are pursuing
various financing alternatives to meet our immediate and long-term financial
requirements. There can be no assurance that additional financing will be
available to us when needed or, if available, that it can be obtained on
commercially reasonable terms. If we are not able to obtain the additional
financing on a timely basis, we will be unable to conduct our operations as
planned, and we will not be able to meet our other obligations as they become
due. In such event, we will be forced to scale down or perhaps even cease our
operations. There is significant uncertainty as to whether we can obtain
additional financing.
Competition
There is strong competition relating to all aspects of the
resource sector. We actively compete for capital, skilled personnel, market
share, and in all other aspects of our operations with a substantial number of
other organizations. These organizations include small development stage
companies like our own, and large, established companies, many of which have
greater technical and financial resources than our company.
Compliance with Government Regulation
The exploration and development of mineral properties is
subject to various United States federal, state and local and foreign
governmental regulations. We may from time to time, be required to obtain
licenses and permits from various governmental authorities in regards to the
exploration of our property interests.
Purchase of Significant Acquisition
Not applicable
Corporate Offices
The address of our principal executive office is Suite 950,
1130 West Pender Street, Vancouver, British Columbia V6E 4A4. Our telephone
number is (604) 602-1675. We have another office located in Kelowna. Our current
locations provide adequate office space for our purposes at this stage of our
development.
Employees
We primarily used the services of sub-contractors and
consultants for our intended business operations. Our only technical employee is
Mr. McAllister, our president and a director.
We entered into a consulting agreement with Mr. Robert
McAllister on December 1, 2007. During the term of this agreement, Mr.
McAllister is to provide corporate administration and consulting services, such
duties and responsibilities to include provision of oil and gas industry
consulting services, strategic corporate and financial planning, management of
the overall business operations of the Company, and supervising office staff and
exploration and oil & gas consultants. Mr. McAllister is reimbursed at the
rate of $2,000 per month. On December 1, 2008, the consulting fee was increased
to $5,000 per month. We may terminate this agreement without prior notice based
on a number of conditions. Mr. McAllister may terminate the agreement at any
time by giving 30 days written notice of his intention to do so. Effective March
1, 2014, the Company entered into a new Management Consulting Agreement
replacing the original agreement with a consulting fee of $6,500 plus GST per
month.
On October 9, 2009, the Company entered into a consulting
agreement with BKB Management Ltd, a corporation organized under the laws of the
Province of British Columbia. BKB Management controlled by the chief financial
officer of the Company. A fee of CAD$4,675 including GST was paid per month. We
may terminate this agreement without prior notice based on a number of
conditions. BKB Management Ltd. may terminate the agreement at any time by
giving 30 days written notice of his intention to do so. Effective April 1,
2011, the fee is CAD$5,500 plus GST. Effective March 1, 2014, the Company
entered into a new Management Consulting Agreement replacing the original
agreement with a consulting fee of CAD$7,500 plus GST per month.
We do not expect any material changes in the number of
employees over the next 12 month period. We do and will continue to outsource
contract employment as needed. However, with project advancements in the health
and wellness and any subsequent programs we may retain additional employees.
Off-Balance Sheet Arrangements
We have no significant off-balance sheet arrangements that have
or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources that are
material to stockholders.
Critical Accounting Policies
Our financial statements and accompanying notes are prepared in
accordance with generally accepted accounting principles used in the United
States of America. Preparing financial statements requires management to make
estimates and assumptions that affect the reported amounts of assets,
liabilities, revenue, and expenses. These estimates and assumptions are affected
by management's application of accounting policies. We believe that
understanding the basis and nature of the estimates and assumptions involved
with the following aspects of our financial statements is critical to an
understanding of our financials.
Mineral Properties
Acquisition costs of mineral rights are initially capitalized
as incurred while exploration and pre-extraction expenditures are expensed as
incurred until such time proven or probable reserves are established for that
project. Acquisition costs include cash consideration and the fair market value
of shares issued on the acquisition of mineral properties.
Expenditures relating to exploration activities are expensed as
incurred and expenditures relating to pre-extraction activities are expensed as
incurred until such time proven or probable reserves are established for that
project, after which subsequent expenditures relating to development activities
for that particular project are capitalized as incurred.
Where proven and probable reserves have been established, the
projects capitalized expenditures are depleted over proven and probable
reserves using the units-of-production method upon commencement of production.
Where proven and probable reserves have not been established, the projects
capitalized expenditures are depleted over the estimated extraction life using
the straight-line method upon commencement of extraction. The Company has not
established proven or probable reserves for any of its projects.
The carrying values of the mineral rights are assessed for
impairment by management on a quarterly basis and as required whenever
indicators of impairment exist. An impairment loss is recognized if it is
determined that the carrying value is not recoverable and exceeds fair
value.
Long-Lived Assets Impairment
In accordance with ASC 360, Accounting for Impairment or
Disposal of Long Lived Assets, the carrying value of long lived assets are
tested for recoverability whenever events or changes in circumstances indicate
that its carrying amount may not be recoverable. The Company recognizes
impairment when the sum of the expected undiscounted future cash flows is less
than the carrying amount of the asset. Impairment losses, if any, are measured
as the excess of the carrying amount of the asset over its estimated fair value.
Revenue Recognition
The Company recognizes revenue from product sales when
persuasive evidence of an arrangement exists, title to product and associated
risk of loss has passed to the customer, the price is fixed or determinable,
collection from the customer is reasonably assured, the Company has no further
performance obligation, and returns can be reasonably estimated.
Going Concern
We have suffered recurring losses from operations. The
continuation of our Company as a going concern is dependent upon our Company
attaining and maintaining profitable operations and/or raising additional
capital. The financial statements do not include any adjustment relating to the
recovery and classification of recorded asset amounts or the amount and
classification of liabilities that might be necessary should our Company
discontinue operations.
The continuation of our business is dependent upon us raising
additional financial support and/or attaining and maintaining profitable levels
of internally generated revenue. The issuance of additional equity securities by
us could result in a significant dilution in the equity interests of our current
stockholders. Obtaining commercial loans, assuming those loans would be
available, will increase our liabilities and future cash commitments.
Recently Issued Accounting Standards
In March 2016, the FASB issued guidance which simplifies
several aspects of accounting for share-based payment award transactions
including income tax consequences, classification of awards as either equity or
liabilities and classification on the statement of cash flows. The guidance is
effective for the Company in the first quarter of fiscal 2018 and earlier
adoption is permitted. The Company is evaluating the impact of adopting this new
accounting guidance on its financial statements.
In June 2016, the FASB issued guidance that changes the
accounting for recognizing impairments of financial assets. Under the new
guidance, credit losses for certain types of financial instruments will be
estimated based on expected losses. The new guidance also modifies the
impairment models for available for-sale debt securities and for purchased
financial assets with credit deterioration since their origination. The guidance
is effective for the Company in the first quarter of fiscal 2021 and earlier
adoption is permitted. The Company is evaluating the impact of adopting this new
accounting guidance on its financial statements.
In May 2015, the FASB issued guidance to remove the requirement
to categorize within the fair value hierarchy all investments for which fair
value is measured using net asset value per share practical expedient. The
guidance is effective for the Company in the first quarter of fiscal 2017 and
early adoption is permitted. The guidance will have no impact on the Companys
balance sheets or statements of operations or cash flows.
In August 2014, the FASB issued guidance on how to account for
and disclose going concern risk. The guidance is effective for the Company in
the second quarter of fiscal 2017 and earlier adoption is permitted. The Company
is evaluating the impact of adopting this new accounting guidance on its
financial statements.
Results of Operations Three Months Ended February 28, 2017
and February 29, 2016
The following summary of our results of operations should be
read in conjunction with our financial statements for the quarter ended November
30, 2016, which are included herein.
Our operating results for the three months ended February 28,
2017, for the three months ended February 29, 2016 and the changes between those
periods for the respective items are summarized as follows:
|
|
Three Months
Ended
February 28, 2017
|
|
Three Months
Ended
February 29, 2016
|
|
Change Between
Three Month Period
Ended
February 28, 2017
and
February 29, 2016
|
Revenue (cost recovery)
|
$
|
Nil
|
$
|
(2,204 )
|
$
|
2,204
|
Cost of Product Sales
|
|
Nil
|
|
1,499
|
|
(1,499 )
|
Other (income) expenses
|
|
Nil
|
|
(10,000 )
|
|
10,000
|
General and administrative
|
|
225,246
|
|
90,348
|
|
134,898
|
Bank charges and interest expense
|
|
561
|
|
2,629
|
|
(2,068 )
|
Consulting fees/Stock Based
|
|
135,704
|
|
50,605
|
|
85,099
|
Compensation
|
|
|
|
|
|
|
Exploration Expenses
|
|
1,160
|
|
Nil
|
|
1,160
|
Professional Fees
|
|
8,321
|
|
(7,956 )
|
|
16,277
|
Net income (loss)
|
|
(225,529 )
|
|
(154,078 )
|
|
(71,451 )
|
Our accumulated losses increased to $12,831,839 at February 28,
2017. Our financial statements report revenue of $nil for the three months ended
February 28, 2017 compared to $2,204 for the three month period ended February
29, 2016. Our financial statements report a net loss of $225,529 for the
three-month period ended February 28, 2017, compared to a net loss of $154,078
for the three-month period ended February 29, 2016. Our net losses have
increased by $71,451 for the three-month period ended February 28, 2017. Our
general and administrative expenses were higher by $134,898 for February 28,
2017 compared to February 29, 2016. The increase was largely due to stock based
compensation of $138,774 for the three-month period ended February 28, 2017,
compared to $37,107 for February 29, 2016. Additionally, higher advertising and
marketing expenses by $45,933 for the three month period ended February 28,
2017, compared to February 29, 2016.
Results of Operations Six Months Ended February 28, 2017
and February 29, 2016
The following summary of our results of operations should be
read in conjunction with our financial statements for the quarter ended February
28, 2017, which are included herein.
Our operating results for the six months ended February 28,
2017, for the six months ended February 29, 2016 and the changes between those
periods for the respective items are summarized as follows:
|
|
Six Months
Ended
February 28, 2017
|
|
Six Months
Ended
February 29, 2016
|
|
Change Between
Six Month Period
Ended
February 28, 2017
and
February 29, 2016
|
Revenue (cost recovery)
|
$
|
Nil
|
$
|
14,014
|
$
|
14,014
|
Cost of Product Sales
|
|
Nil
|
|
7,515
|
|
(7,515 )
|
Other (income) expenses
|
|
Nil
|
|
(20,000 )
|
|
20,000
|
General and administrative
|
|
403,557
|
|
285,416
|
|
118,141
|
Bank charges and interest
expense
|
|
1,813
|
|
4,616
|
|
(2,803 )
|
Consulting fees/Stock Based
|
|
214,478
|
|
141,486
|
|
72,992
|
Compensation
|
|
|
|
|
|
|
Exploration Expenses
|
|
32,669
|
|
nil
|
|
32,669
|
Professional Fees
|
|
29,457
|
|
53,742
|
|
(24,195 )
|
Net income (loss)
|
|
(391,242 )
|
|
(303,966 )
|
|
87,276
|
Our accumulated losses increased to $12,831,839 as at February
28, 2017. Our financial statements report a net loss of $391,242 for the six
month period ended February 28, 2017, compared to a net loss of $303,966 for the
six month period ended February 29, 2016. Our net losses have increased by
$87,276 for the six month period ended February 28, 2017, our general and
administrative expenses were higher by $118,141 for February 28, 2017 compared
to February 29, 2016. The increase was due to higher consulting and stock based
compensation costs of 214,478 for the six month period ended February 28, 2017,
compared to $141,486 for February 29, 2016. The high costs during 2016 costs
were largely due to granting stock options to various consultants. Additionally,
higher advertising and marketing expenses by $58,513 for the six month period
ended February 28, 2017, compared to February 29, 2016.
As at February 28, 2017, we had $416,676 in current
liabilities. The increase is largely due to increase in payables and amounts due
to related parties. Our net cash used in operating activities for the six months
ended February 28, 2017 was $200,594 compared to $139,723 used in the six months
ended February 29, 2016. The increase in cash used in operating activities was
in increased expenses due to the lithium technology operations.
Our total liabilities as of February 28, 2017 were $416,676 as
compared to total liabilities of $376,499 as of August 31, 2016.
Liquidity and Financial Condition
Working Capital
|
|
|
|
|
|
|
|
|
At February 28,
|
|
|
At August 31,
|
|
|
|
2017
|
|
|
2016
|
|
Current assets
|
$
|
189,058
|
|
$
|
144,112
|
|
Current liabilities
|
|
(416,676
|
)
|
|
(376,499
|
)
|
Working capital (deficiency)
|
$
|
(227,618
|
)
|
$
|
(232,387
|
)
|
Cash Flows
|
|
|
|
|
|
|
|
|
Six Months
Ended
|
|
|
|
February 28,
|
|
|
February 29,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Cash flows (used in)
operating activities
|
$
|
(200,594
|
)
|
$
|
(139,723
|
)
|
Cash flows from financing activities
|
|
246,618
|
|
|
Nil
|
|
Cash flows from investing
activities
|
|
16,097
|
|
|
93,911
|
|
Net increase (decrease) in cash during period
|
$
|
62,121
|
|
$
|
(45,812
|
)
|
Operating Activities
Net cash used in operating activities was $200,594 in the six
months ended February 28, 2017 compared with net cash used in operating
activities of $139,723 in the same period in 2016. The increase in cash used
mostly results from increased operating costs incurred in the current period
from the expenses in mineral expenses.
Financing Activities
Net cash provided by financing activities was $246,618 in the
six months ended February 28, 2017 compared to $nil the same period in 2017. The
cash provided was from the private placements.
Investing Activities
Net cash provided in investing activities was $16,097 in the
six months ended February 28, 2017 compared to $93,911 in the same period in
2016. The cash provided was form sale of marketable securities and purchase of
Lithium Brine properties.
Revenue comparisons for the Quarter ended February 28,
2017 compared to the quarter ended February 29, 2016
For the six month period ended February 28, 2017, the Company
had $nil in revenues compared to $14,014 in revenues for the same six month
period in the prior year. Product line was discontinued as at August 31, 2016.